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Abstract
Nanotechnology is a rapidly expanding field and is expected to revolutionize many
existing industries and create entirely new ones. Presently, and to a greater extent in the
future, there is potential for occupational exposure to free forms of these materials in
research and development labs and industrial processes. Free nanomaterials may pose a
significant health risk to those exposed as described by recent preliminary data on
nanomaterials but also through the work addressing exposures to ultrafine particles both
in the workplace and in ambient air. There are presently no published health and safety
guidelines for working with nanomaterials. This paper proposes a general frame work for
classifying these materials and recommends appropriate hypothetical precautions to allow



















This graduate thesis is a limited review of the topic ofnanotechnology primarily in the
scientific literature with an emphasis on the potential risks associated with occupational
exposure. This review has evaluated the current information on nanotechnology
toxicology, dose response data, routes of exposure, and other information related to risk
characterization and analysis. The author has also interviewed or reviewed the opinions
ofexperts in the field ofnanotechnology to further elucidate occupational safety and
health issues including the need for regulation and control of exposure to these materials
in the workplace, concentrating in research and development laboratories and
manufacturing. Included are recommendations on specific approaches to working,safely
with nanomaterials in the laboratory. The goal of this endeavor is to explain the health
and safety issues surrounding these materials and suggest preliminary ways to work
safelywith them, based on the limited information available. The primary research
questions asked are:
1.) What is the current state ofknowledge concerning occupational exposure risk
associated with nanotechnology?
2.) What are the areas of agreement and disagreement concerning nanotechnology
safety in the literature and among the experts, and what additional research is
required to generate a more complete picture of the health and safety problems
surrounding the issue?
3.) What occupational safety precautionary recommendations can be made for
research laboratory staffbased on the current state ofknowledge concerning the
known risks ofnanotechnology?
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Nanotechnology is significant to the environmental health and safety (EHS) field and
to this author for several reasons. It is an industry that is still in its infancy and there is a
tremendous opportunity to proactively address potential environmental and health risks
prior its use in occupational settings or by the general public rather than reacting when
environmental degradation or health effects occur. While the United States government
is keenly aware of the societal issues surrounding nanotechnology due to the
biotechnology public relations failure of the 1990's and the associated consumer
backlash, it is actively working to garner public acceptance of it (Weiss 1). However,
little has been done to study and address potential environmental, health and safety issues
thatmay arise from its use ("No Small
Matter"
3). Based on a recent literature search
there is no comprehensive guidance available to address working safelywith these
materials and it is hoped that this thesis will begin to effectively address a portion of this
EHS issue and delineate areas that require additional study.
Nanotechnology is currently going through a period of rapid growth due to strategic
funding supplied not only by major corporations but also from many industrialized
countries. It is expected to have an effect on the world economy similar to the industrial
revolution of the late 19th century. In fact, "government officials have called
nanotechnology the foundation for the 'next industrial
revolution'
worth an estimated
trillion dollars within the coming
decade"
(Weiss 1). It is projected to transform existing
industries and also spur the creation of entirely new ones. The fields expected to be
transformed by nanotechnology include material fabrication, manufacturing, medicine,
healthcare, environmental protection, energy, agriculture, biotechnology, electronics,
information technology and national security (Rocco and Bainbridge 2). Worldwide
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several government and business alliances have been formed to address various business
opportunities in the field ofnanotechnology again with little emphasis on environmental
health and safety. The stakes in this game are not small, the United Kingdom's
Department ofTrade and Industry estimates that by 2005 the market for nanotechnology
applications will reach over $100 billion dollars (Arnall 6).
Here in the United States, nanotechnology has been put at the forefront ofnational
research and developmentwith the National Nanotechnology Initiative (NNI) of2001 .
The NNI was developed by the Clinton Administration and was approved by Congress in
November of2000. As a result of the NNI in that year a total of $422 million dollars was
spread over six departments and agencies (Roco and Bainbridge 1). The allocation of
funds has increased steadily with current estimated budget for 2004 at $961 million and a
proposed budget of $982 million for 2005 ("NNI Budget"). These allocations have
grown to include both the Environmental Protection Agency (EPA) and also theNational
Institute ofOccupational Safety and Health (NIOSH) through the National Institutes of
Health (NIH) as a part of the Department ofHealth and Human Services. However, the
emphasis is still on applications for this technology rather than the implications of its use.
Even within the field of environmental nanotechnologywhere the science is seen as a
boon to environmental remediation only now is this technology being assessed as a
potential environmental threat. "Aside from worries about the direct health implications,




The applications ofnanotechnology are expected to increase significantly over the
coming decade and as a result the materials arising from these new processes will
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eventually present themselves to the EHS specialist. The worldwide annual industrial
production in the nanotechnology sectors is expected to exceed a 1 trillion dollarmark in
10 to 15 years (Roco and Bainbridge 3) and employ about 2 million workers (Roco 1).
According to Kliener and Hogan, 2.5 tons ofnanomaterials are produced each year
around the world with halfof the sixteen producers located in the United States (3). The
application ofnanotechnology is so broad and the materials created are so varied that not
all materials arising from it will be hazardous, but there is some recent supporting
evidence, albeit preliminary, that identifies some types ofnanomaterials as potentially
hazardous (Borm 320; E. Oberdorster 1061; "Nanoscience and
nanotechnologies"
4).
It appears that there will be few areas of the manufacturing and service industries that
will not be affected by nanotechnology during the next 20 years. Thus, EHS
professionals will in the near future either have to address nanotechnology exposure
issues directly through new or existing commercial processes within their organizations
or address use and disposal issues related to purchased materials and equipment that
contain nanomaterials.
A preliminary review of the literature on nanotechnology reveals hundreds ofpapers
and articles concerning nanotechnology, the vast majority ofwhich address the expected
benefits or damage associated with the real or imagined use of this technology. These
documents are meant for the arena ofpublic opinion and politics and provide little in the
way of substantial scientific evidence. Unfortunately, very little has been written in the
scientific literature on the potential for environmental damage and fewer documents exist
that address risk, toxicity and the mechanisms of exposure in the occupational setting. As
a result, EHS professionals should be required to take a precautionary approach when
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working with nanomaterials. It was suggested in an e-mail from Dr. AndrewMaynard
of the NIOSH that this lack of information on nanotechnology materials be addressed
using data on ultrafine particles which have a diameter of 0.1 microns (100 nanometers)
or less ("RE: Nanotechnology"). It was inferred that this information could then be
applied to the issues surrounding occupational exposure to nanomaterials. Also, in July
of 2004, the Royal Society and The Royal Academy ofEngineering published a
preliminary report, "Nanoscience andNanotechnologies: opportunities and
uncertainties"
in which much of the data presented and the conclusions and recommendations reached
are based on research done in large part with ultrafine particles.
The findings of the Royal Academies also validate several of the author's predicted
conclusions for this paper including applying the Precautionary Principle to occupational
exposure ofnanomaterials. The Precautionary Principle requires thatmaterials be
considered to be hazardous until proven otherwise and are handled accordingly in the
interim. Based on the information gathered it has been possible to propose a preliminary
approach to working safely with nanomaterials by applying existing precautionary
control measures including engineering controls and personal protective equipment.
1.1 Definitions
Dose - the amount of a substance that will reach a specific biological system, and is a
function of the amount to which the individual is exposed, namely the exposure, taking
account of the fact that a proportion is eliminated by the body's natural defenses and does




Exposure - the concentration of the substance in the relevant medium (air, food, water)
multiplied by the duration of contact ("Nanoscience and
nanotechnologies"
36).
Fullerenes - a form of carbon having a large spheroidal molecule consisting of an empty
cage of sixty or more carbon atoms ("Hyperdictionary.com").
Hazard - the potential to cause harm: hazard is typically assessed by toxicology, for
example testing harmful potential on cultured cells or isolated organs (in vitro) or directly
on laboratory animals or humans (in vivo). Another hazard is the potential for clouds of
combustible nanoparticles to explode ("Nanoscience and
nanotechnologies"
36).
Nanobots - self replicating nanomachines used to create materials one atom at a time in
precise order and configuration (Arnall 16).
Nanometer - one billionth of ameter.
Nanoscience - the study ofphenomena and manipulation ofmaterials at atomic,
molecular andmacromolecular scales, where properties differ significantly from those at
a larger scale ("Nanoscience and
nanotechnologies"
5).
Nanotechnology - the design, characterization, production and application of structures,





Nanotubes - carbon based structures composed of a single layer of atoms in a cylindrical
arrangement about 1 .5 nm wide and up to 1 millimeter in length, multiple concentric
rings may also form, creating tubes of a much larger diameter (Maynard, et al. 88).
Quantum Dots - nanoscale crystals made of a semiconductormaterial which can emit
light in a multitude of colors ("Cancer
Nanotechnology"
11).
Risk - a quantification of the likelihood of such harm occurring: risk is assessed from
consideration of the likelihood ofexposure, the dose and the inherent toxicity of the
substance to which people or other organisms may be exposed. Sometimes, in the case of
materials to which exposure has already occurred, riskmay be measured directly by the
techniques of epidemiology ("Nanoscience and
nanotechnologies"
36).
Ultrafine particles - particles with a diameter of less than 100 nm which are ubiquitous in
the indoor and outdoor ambient atmosphere and originate frommany anthropogenic and
natural sources (G. Oberdorster, et al. 438).
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Chapter 2.0 Background
The root of the word nanotechnology is nanos which comes from the Greek work for
dwarf. The word nanotechnology was coined by K. Eric Drexler in 1 986 in his book
Engines ofCreation: The Coming Era ofNanotechnology. In that book Dr. Drexler
describes a world with tremendous wealth, where in an unpolluted environment; every
need is met by nanotechnology. This idyllic world vision has been embraced by the
industrialized world with countries and companies vying for position as the world's
leader in nanotechnology.
The concept ofnanotechnology has been on the minds of scientists for centuries. The
Scottish physicist, James Maxwell in 1871 imaged tiny demons that could move atoms
(Keiper 2). It was not until December 29, 1959 when the concept ofnanotechnology was
clearly defined in a speech given by the Nobel Prize winner Richard Phillips Feyman. In
that speech, entitled "There's Plenty ofRoom at the
Bottom,"
Dr. Feyman talks of a class
ofminute materials beyond the scale ofminiaturization in which atoms are rearranged to
make small switches and machines.
Nanotechnology is
based on the recently developed ability to measure,
manipulate and organize matter on the nanoscale - 1 to 100
billionths of ameter [. .
.]
The nanoscale is not just another
step toward miniaturization, but a qualitatively new scale.
The new behavior is dominated by quantum mechanics,
material confinement in small structures, large interfacial
volume fraction and other unique properties, phenomenon
and process. (Rocco and Bainbridge 1)
It has been found thatmaterials composed of elements that are considered to be either
inert or otherwise innocuous, such as gold, develop unexpected properties, such as altered




A01). It is these new observed and theorized behaviors of
materials that are ofparticular concern to the EHS specialist for their potential to cause
harm to humans and the environment.
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3.0Methodology
The purpose of this literature review was to organize information pertaining to
nanotechnology and the occupational safety and health issues surrounding it. The
information was gathered for this thesis from various sources including bound literature,
periodicals, newspapers and published articles accessed either on the world wide web,
through the Rochester Institute ofTechnology document retrieval system or from review
ofpopular literature. Additionally, the author also reviewed information on nanoparticles
found on various websites. Information from a limited number of interviews with leading
experts in this field or reviews of their published opinions was also used. Preliminary
questions asked pertained to requesting information concerning the risk and/or
toxicological impact ofnanomaterials as well as the any health and safety studies that
have been done on any aspect of this technology. Later questions to nanotechnology and
particulate experts fromNIOSH included inquires related to the best available technology
via engineering controls that can effectively control nanoparticulates in the work place.
Additional opinions from leading experts in the field ofnanotechnology were ascertained
from existing interviews or editorials making actual interviews unnecessary.
3.1 Literature Review
This literature review was a distillation of the findings from current and past scientific
studies concerning nanotechnology with an emphasis
on information pertinent to
occupational exposures. There was also a limited review ofbound literature. The
subjects addressed in these books include ultrafine particles, toxicology and containment
technologies. The acquired information was organized and compared to identify areas of
agreement and areas where information is either lacking or contradicted. The primary
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purpose of the review was to identify within the literature information that provides a
basis to complete a scientific risk assessment and risk analysis of the occupational
exposures to nanomaterials and propose a mechanism of regulation and control of
exposures in the workplace.
3.2 Expert Interviews
Telephone and e-mail interviews were conducted with several experts or their
representatives in the field ofnanotechnology (or their published opinions were
reviewed) in an effort to answer questions concerning the use ofproper engineering
controls and personal protective equipment, regulatory issues and to provide insight into
those areas where information is lacking. The interview candidates included Dr. Andrew
Maynard, Ph.D. of the NIOSH Division ofApplied Research and Technology and
Vincent Castranova, Ph.D., NIOSHNanotechnology Safety and Health Research
Coordinator. They were asked questions about available information concerning the
known heath hazards and risks associated with nanomaterials, the existence of any EHS
guidelines concerning their use as well as the effectiveness of existing engineering
controls and personal protective equipment. Anticipated questions for other leading
experts in the field ofnanotechnology including Vicki Colvin, Executive Director of the
Center for Biological and Environmental Nanotechnology at Rice University, Tim
Harper, the founder ofCMP Cientifica and Executive Director of the European
NanoBusiness Association and PatMooney, founder and Executive Director ofErosion,
Technology and Concentration (ETC) , were to include to what degree, if any, regulation
was needed to ensure that this technology is used safely. However, the author was able
ascertain these opinions from existing published interviews or editorials making actual
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interviews unnecessary. Dr. Colvin was also asked about the availability ofEHS
guidelines. Appendix B contains a list ofquestions asked or that were intended to be
asked of these experts. Their answers are included in the Chapter 4.0 Literature Review
and Chapter 5.0 Results and Discussion.
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Chapter 4.0 Literature Review
4.1 Introduction
In the international rush for supremacy in the field ofnanotechnology there appears to
have been little thought given to investigating how this technology will impact the
environment and also the health and safety of researchers, manufacturing employees and
others who may face significant occupational exposures to these materials now and in the
future.
Nanoscale materials, primarily in the form ofnanoparticles, have already been used
commercially in products intended for the general public. These materials have been
used in existing applications including sunscreens, cosmetics, tennis racquets and other
commercial products ("Nano's Troubled
Waters"
1). At this point the author is unable to
find any reports of adverse reactions due specifically to these materials but it has been
hypothesized that nanoparticles made of titanium dioxide which are commonly used in
transparent sunscreens become photo-reactive upon exposure to sunlight andmay cause
oxidative stress to the skin ("No Small
Matter"
7). Additionally, it has been found that
particles less than 1 micron (wm) in diameter can penetrate far enough into the skin to be
taken up by the lymph system (Howard). However, a recent study on the application of
nanoparticulates of titanium oxide to intact skin indicates that this material does not fully
penetrate viable skin tissue (Lademann et al. 247).
4.2 Nanotechnology Defined
Nanomaterials by definition do not exceed 100 nms. To put this into perspective one
nm is approximately the width of 10 hydrogen atoms (Feder 2). Cold viruses are
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generally 50 nms in length (Rotman 72). This technology therefore approaches the size
limits ofmatter.
As predicted in Dr.
Feyman'
s lecture this technology is now driven by mankind's
recent ability to visualize measure and physicallymanipulate matter on the atomic scale.
The watershed moment occurred in 1 98 1 when a team of scientists from IBM invented
the scanning tunneling microscope. The device uses a fine needle and extremely low
electric current to detect the height of individual atoms. This microscope was able to not
only visualize molecules but also contact, move and precisely place individual atoms
(Keiper 3). Since thenman's ability to visualize and manipulate matter on the atomic
level has steadily improved.
There are many ways to classify the various facets of the nanotechnology field. For
the purposes of this thesis a useful classification system relies on howmaterials are made
on the nanoscale (1 to 100 nanometers) whether it is from the top down versus the bottom
up. Top down technology is not new and can be termed a more refined version of
chemical engineering involving more sophisticated and precise tools (Keiper 3). The top
down method is really a form ofminiaturization and is currently howmost nanomaterials
are manufactured "producing very small structures from larger pieces ofmaterial, for





3). Examples of this include industrial processes in the
semiconductor and microchip industries which are continually striving for more effective
methods ofminiaturization and mechanical attrition processes such as grinding, milling
and alloying (Aitken, Creely, and Tran 26).
McShane 15
The bottom up method involves using atoms ormolecules to arrange themselves into
a structure due to their natural properties ("Nanoscience and
nanotechnologies"
3).
Atoms can now be moved manually but while this 'positional
assembly'
offers greater
control over construction, it is currently very laborious and not suitable for industrial
applications ("Nanoscience and
nanotechnologies"
3). Other scenarios which have yet to
be realized involve using nanomachines to create materials one atom at a time in precise
order and configuration (Arnall 16). This bottom up approach has also been termed
molecularmanufacturing. It is expected in the coming years that bottom up
manufacturing will dominate this field as new; more precise and intricate manufacturing
processes are developed. It is also where the more exciting properties ofnanomaterials
are seen due to the effect that quantummechanics has at the atomic and molecular level
which "gives them bizarre but useful physical
properties"
(Akin 134). Currently the
bottom up approach has only been used to make a limited number of types of
nanoparticles. The manufacturing processes are not optimized; in particular, the
manufacture of carbon nanotubes has proven difficult due to inherent deficiencies in the
manufacturing processes which are currently unable to produce a uniform product in
discreet units ("Nanoscience and
nanotechnologies"
3). It is currently in the bottom up
approach where most of the innovation and rapid technological development is taking
place.
The bottom up approach is also where the presently imaginary nanobots reside. It is in
relation to these entities in which the dire doomsday warnings appear and also which
have captured the imagination of the public, for good or bad. In this scenario, which K.
Eric Drexler cites in his 1986 book Engines ofCreation: The Coming Era of
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Nanotechnology. molecularmanufacturing occurs by which self replicating
nanomachines are used to make anything desired. The machines would simply need the
necessary elements to be supplied as raw materials to build atom by atom finished
products, both biological and inert, without waste or any other form ofpollution
(Baum37). It is the fear of self replicating nanobots gone wild, as described by Drexler,
consuming everything on earth as they proliferate geometrically, that has caught the
public's imagination and has spawned the specter of the earth and everything in it being
reduced to 'gray
goo'
at the hands of these nanobots. Currently the state of the art is
nowhere near this level. To put the progress of this technology in perspective, in August
of2001 scientists from the University ofOsaka built a nanoscale spring, the first and
smallestmicromechanical system ever. While this is a significant achievement, it is far
from the complex molecular factory envisioned as a basis for this technological approach
(Arnall 33).
It is generally assumed thatmolecularmanufacturing is years or possibly decades
away. There is also a school of thoughtwhich maintains that building suchmachines is
physically impossible. Chief among these detractors is Richard E. Smalley ofRice
University, aNobel Prize winner for the discovery of fullerenes. Dr. Smalley believes
that not only are nanofactories physically impossible to create but that the concern
generated by the threat ofmolecular assemblers (nanomachines or nanobots) threatens
the entire field ofnanotechnology (Baum 37).
4.3 The Debate
The public debate surrounding nanotechnology has a familiar ring to it. When asked
about nanotechnology, those who were aware of it in Great Britain compared it with
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geneticallymodified organisms ("Nanoscience and
nanotechnologies"
6). In the 1990's
the biotechnology community and its genetically modified foods went through a public
relations crisis (EichenwaldAl). Much of the policy making for this technology was
performed in a vacuum where regulators and industry leaders formed policy without the
input ofother concerned stakeholders (EichenwaldAl). The biotech industry was unable
to prove that their products were risk free and have since allowed the anti-biotech
activists to set the agenda for the debate. As a result, Susan Huttner, the vice provost for
research for the University ofCalifornia system states, "We have become slaves to the
[continuing]
controversy"
(Hesman C8). The nanotech industry along with supporting
governments are attempting to not repeat the mistakes of the biotech industry and are
seeking to include all stakeholders in the public policy process in order to foster
acceptance of the technology by the general public.
The commercial participants in the debate include the current nanotechnology industry
leaders such as Dupont and industrial organizations such as the NanoBusiness Alliance
which includes LockheedMartin, Praxair, Zyvex, NanoFilm, venture capitalists, lawyers
and also a representative from the U.S. EPA. The Alliance has been formed to address
and prevent the extreme views of a nanotechnology nightmare as proclaimed by anti-
nanotechnology activists from impacting the current debate (Feder 2).
The governments providing funding for further research and involved in the debate
include the United States through its NationalNanotechnology Initiative (NNI), Japan
with its Expert Group onNanotechnology through theirMinistry ofEconomy, Trade and
Industry and the European Commission which funds nanoscience research through its
Framework Programme (Arnall 19). Most of these national programs are actively
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seeking the input of stakeholders in order to incorporate environmental concerns into the
policy making process. Significantly, only limited amounts of funding from these
governmental entities has been allocated for research and development of environmental
applications ofnanotechnology, and only recently have endeavors to explore
environmental risks arising from the use of this technology surfaced.
On the other side of the debate lies the non-governmental organization (NGO) the
Action Group on Erosion Technology and Concentration (ETC) under its former name of
Rural Advancement Foundation International was responsible in large part for fomenting
the backlash to the use ofbiologically engineered crops in Europe. The Group's
Executive Director, PatMooney, has called for a temporary moratorium on commercial
production ofnanomaterials until the risks are better elucidated and regulations are
promulgated to control environmental, health and safety impacts (Weiss "For
Science"
A01).
Given the strategic economic importance ofnanotechnology, it is highly unlikely that
aworld-wide ban on nanomaterials will occur. In fact one other significant NGO,
Greenpeace, has proclaimed a more moderate approach than ETC on the issue. In that
report Greenpeace author, Alexander Arnall, states "an externally imposed
nanotechnology moratorium seems both impractical and probably damaging at
present"
(41).
The issues surrounding the debate primarily have to do with the anticipated benefits
and environmental costs of this technology. According to the promoters of the
technology, it will cause nothing short of a transformation in the way people live.
Simply put it will affect almost every aspect of our lives,
from the medicines we use, to the power of our computers,
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the energy supplies we require, the food we eat, the cars we
drive, the buildings we live in and the clothes we wear.
More importantly, for every areawhere we can imagine an
impact, there will be others no one has thought of- new
capabilities, new products, new markets. (Holister 5)
Since this technology is thought to have such a potential impact on daily life, the
worldwide economic potential and the wealth derived from it are expected to be
tremendous. Thus, the strategic positioning and funding for this field is ofutmost
importance, and there has been little thought given to what other consequences can occur
as a result of its use.
On July 29, 2004 the Royal Society and the Royal Society ofEngineering
published "Nanoscience and nanotechnologies: opportunities and
uncertainties"
which is
a comprehensive report on the state of the industry and the societal, environmental and
health issues it raises. The committee work group was composed of experts in the field
ofnanotechnology in both industry and academia including ethicists, scientists,
engineers, health, environment and consumer affairs ("Nanoscience and
nanotechnologies"
2). This report stated that a case for a moratorium (as proposed by
ETC) has not beenmade, and that while the nanotechnology industry does need to be
regulated, the regulation must be appropriate to the, as yet unproven, risk.
The middle ground for the debate is not quite as clear cut. Stakeholders all agree that
there needs to be more research on the risks of the technology, but they disagree on
whether regulation is needed and how these regulations or recommendations should be
promulgated. Vicki Colvin stated in an interview published in April of 2003 that "in the
next few years, the answer is no (to regulation of
nanomaterials)."
However, she does
feel in the future "that eventually there will be a regulatory component to this
industry"
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(Rotman 72). As Tim Harper ofCMP Cientifica (a nanotechnology industry information
company) states:
From a business standpoint, we simply want to know what
the rules are, or will be. Nobody wants to risk investing in
the production ofmaterials thatmay be banned at some
stage in the future, ormay be subject to the same sort of
regulation as pharmaceuticals, which would dramatically
affect the viability of a whole sector of industry. (Harper)
As part of the "Nanoscience and
nanotechnologies"
report, the public in the United
Kingdom was polled on the public's awareness and general attitude toward
nanotechnology which is crucial to societal acceptance of this technology. The report
found that:
Public awareness ofnanotechnologies is low in Great
Britain. In the survey ofpublic opinion that we
commissioned, only 29% said they had heard of
'nanotechnology'
and only 19% could offer any form of
definition. Of those who could offer a definition, 68% felt
that it would improve life in the future, compared to only




Currently the majority of the concerns expressed by stakeholders involve the impact this
technology will have on the environment and public health.
Almost all of the concerns expressed to us, in evidence and
during our workshop on health and environmental impacts
ofnanotechnologies, related to the potential impacts of
manufactured nanoparticles and nanotubes [in the free
rather than fixed form] on the health and safety ofhumans,
non-human biota and ecosystems. ("Nanoscience and
nanotechnologies"
35)
While how these materials will be regulated environmentally was a concern of the public,
unfortunately, either no question was asked or no opinion was expressed specific to the
health impact occupational exposures will have on workers where airborne
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concentrations ofnanomaterials would presumably be orders ofmagnitude higher than
any found in the ambient environment.
4.4 Types ofNanomaterials
Currently the most ubiquitous types ofnanoparticulates are finely scaled particles of
single elements ormolecules such as carbon or titanium dioxide. Nanoparticulates also
include constructs such as quantum dots which can act as semiconductors, are a





can be as small as 2 nm in diameter ("Nanoscience and
nanotechnologies"
10). Another
type is a ball-shaped latticework of 60 carbon atoms called buckminster fullerenes,
fullerenes or bucky balls named for Buckminster Fuller, the inventor of the geodesic
dome. Fullerenes, which are hollow, can be used in the pharmaceutical industry for drug
delivery, for energy production in fuel cells, for environmental remediation and
lubrication, and for catalytic nanoparticles which are used in various commercial
chemical reactions. The size of these particles varies; fullerenes are 1 nm in size and
nano catalysts are 1 to 10 runs in length (Arnall 15).
There are currently two types ofnanotube constructs. The first is a single-walled
construct and the second is amultilayered design. These constructs typically have an
interior diameter of 5 nm and an outer diameter of 1 0 runs (Amall 15). A smaller
diameter tube of 1 .5 nm and up to 1 millimeter in length was also reported byMaynard,
et al. (88). Nanotubes exhibit high tensile strength, high conductivity, large surface area,
unique electronic properties and may have high molecular storage capacity. The fields
potentially impacted by this technology are electronics, high strengthmaterials, quantum
wire and mechanical memory (Maynard et al. 88). The production process for these
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materials involves the use ofa transition metal particle as a catalyst in the presence of
molecular carbon at high temperature or pressure. The two processes described in
Maynard, et al., involve the use of lasers or high pressure carbon monoxide.
4.5 CurrentManufacturing Processes
Currently there are four general types ofpublicly knownmanufacturing processes for
nanomaterials, "all ofwhichmay potentially result in exposure by inhalation, dermal or
ingestion routes [. .
.]
to agglomerated particles during recovery, powder handling and
product
processing"
(Aitken, Creely and Tran 57).
The first bottom up approach is gas phase synthesis in which the raw material is
evaporated using a furnace, laser or plasma evaporation "followed by a homogenous
nucleation and a further condensation and coalescence of
particles"
(Gleiche and
Hoffschulz 29). Of the fourmanufacturing processes "only the gas-phase processes have
the potential to cause exposure to primary nanoparticles by inhalation during the
synthesis
phase"
(Aitken, Creely and Tran 57). Gas phase synthesis includes flame
pyrolysis used in the production of fumed silica and ultrafine titanium dioxide. Two gas
phase synthesis processes were described byMaynard et al. for the production of carbon
nanotubes. They are the laser ablation process and the high pressure carbonmonoxide
process (HiPCO). "The laser ablation process involves formation of a carbon plug, which
contains an intimate mixture of catalyst (usually Iron (Fe) and/orNickel (Ni)), and its
ablation by laser in an inert gas stream. The resulting material is collected downstream in
a cold finger trap [....] the collected product is fairly compact and its fibers are relatively
difficult to
separate"
(89). The carbon plug provides the raw material and needs regular
replacementmaking this is a batch process. The second process, HiPCO,
McShane 23
involves (the) introduction ofultrafine Fe or a combination
ofFe andNi metal catalyst particles into a high
pressure/high temperature carbon monoxide (CO) gas
stream. The product is collected onto a filter and since it is
produced in the gas phase, forms a much expandedmat of
fibers. (89)
Colloidal methods, another bottom up process, involve wet chemistry precipitation
reactions which are relatively inexpensive to perform and are a reliable and well
established means ofproducing nanomaterials (Aitken, Creely and Tran 25). The sol-gel
process which "is awet chemical procedure based on an initial liquid and colloidal
'sol'
is one such method in which the product of the process is a solid structure "gel".
"Different drying procedures will form a glassy or ceramic structure, whereby thin
coatings, fibers, aerogels and powders can be
obtained"
(Gleiche and Hoffschulz 29).
The vapor depositionmethod, the last bottom up approach, is a process in which
"vapour is formed in a reaction chamber by pyrolysis, reduction, oxidation and nitridation
... to deposit thin films of silicon and other semiconductors on to semiconductor
wafers"
(Aitken, Creely and Tran 25). Colloidal methods may also involve the use ofultrasound
radiation used to induce chemical reactions (Aitken, Creely and Tran 26).
Attrition methods involve top down processes in which smaller particles are produced
from larger ones. The processes primarily involve wet milling ofmaterials such as clays
and metals. The suspensions can be produced at the rate of tons per hour which must be
stabilized to prevent agglomeration (Aitken, Creely and Tran 26).
This survey ofmanufacturing processes is by no means exhaustive. There may be
other types ofmanufacturing processes in use in the nanotechnology industry today, but
specific information on the processes was not found by the author and may be
proprietary.
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4.6 Risks Associated with Nanomaterials
The United States Environmental Protection Agency (EPA) defines risk using the
following formula:
Hazard x Exposure = Risk




1). Based on this definition the literature does not currently address
the occupational risks associated with exposures to nanomaterials. However, there are
only a few studies that have been completed which begin to address the toxicity hazards
specific to manufactured nanomaterials in laboratory animals as well as effects on various
target organs in anticipation of identifying routes of exposure in the occupational setting.
Nanoparticulates are of special concern because by virtue of their size, they exhibit
significantly greater hazardous properties than larger particles consisting of the same
material ("Nanoscience and
nanotechnologies"
80). It is the same properties thatmake
this material an item of interest to industry, such as surface reactivity and the ability to
cross cell membranes that also make it a safety and health risk. After a skin or inhalation
exposure, for instance, it is thought that these materials may end up in areas of the body
relatively distant from the exposure site and cause harm
through inflammation and other
disease causing mechanisms. As a result, materials originally
thought to be inert have
drastically different and generally harmful properties on the nanoscale ("Nanoscience and
nanotechnologies"
4).
The literature cites in several places that nanotechnology is not new nor is man's
exposure to nanoscale particulates. The production ofmetal colloids dates back several
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centuries (Aitken, Creely and Tran 26). Dr. C. Vyvyan Howard notes that there have
always been ultrafine particles and exposure to them, mainly consisting ofminute
crystals of salt which become airborne through the action of the
oceans'
waves and with
the advent of the use of fire, the exposure to the products of combustion ("No Small
MatterAnnex").
It would be logical at this juncture to mention the issue ofnanoparticles versus
ultrafine particles. The previous historical examples refer primarily to ultrafine particles
which like nanoparticles occur in the size range of less than 100 nms. The difference,
however, may be significant in that true nanoparticles are engineered atom by atom and
may exhibit different properties from ultrafine particulates which are generally found in
ambient exposures as a by-product ofone ofmany processes including combustion,
aerosol generation, welding, etc.
A review of the literature concerning nanoparticulates has revealed a very preliminary
body ofwork on the health effects ofnanotubes, fullerenes and quantum dots. The
majority of information on the potential health effects ofnanoparticulates in general
resides in the work performed by researchers working in the field ofparticulate
toxicology and, in particular, revolving around their work with ultrafine particles. The
use ofultrafine particle studies as surrogates to extrapolate the potential effects of
engineered nanoparticulates has been validated by the work that The Royal Society and
the Royal Academy ofEngineers has done for their report "Nanoscience and
nanotechnologies: opportunities and
uncertainties."
This committee of experts has based
their preliminary conclusions concerning nanomaterials in large part on the
investigational work done with ultrafine particles. In this report the committee makes no
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real distinction between ultrafine and nanoparticulates. "Few studies have been published
on the effects of inhaling free manufactured nanoparticles and we have had to rely mainly
on analogies with results from studies on exposure to other small particles - such as the
pollutant nanoparticles known to be present in large numbers in urban air, and the
mineral dusts in some
workplaces"
(4).
Whether it is an ultrafine or a nanoparticulate, Dr. Vyvyan Howard, an aerosol expert
from the University ofLiverpool, reported in the Annex to the ETC article "Size
Matters"
that the size of the particulates more than properties of the element itself are what seem to
determine toxicity. These nanoscale particles appear to cause inflammation to the tissues
to which they are exposed and produce free radicals that cause cellular damage. Also,
due to their exceedingly small size, they also have the ability to enter the body through
various pathways including intact skin.
4.7 Routes ofExposure
It is the unfixed or free forms ofnanomaterials that are of concern and pose a potential
occupational exposure risk to laboratory researchers and workers manufacturing them.
Since the risk ofharm depends upon a hazardous material reaching the target organ
("Nanoscience and
nanotechnologies"
36) the exposure mechanisms by which these
materials can get into the body are ofutmost importance.
Inhalation is identified as the major route of exposure in the occupational setting for
free nanoparticles; skin contact follows as the next most common route of exposure
("Nanoscience and
nanotechnologies"
36). One exception to this statement may be
unrefined carbon nanotubes. Evidence has been reported that skin contact from
nanotubes rather than inhalationmay be a more significant route of exposure in
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occupational settings (Maynard, et.al 106). Future ingestion issues for food and drink
were also cited should suchmaterials be added to food. Injection may also occur as these
materials are used in medical procedures ("Nanoscience and
nanotechnologies"
36).
Overall very little is known about the actual routes of exposures for nanomaterials.
Several recent papers address exposure issues related to handling nanotubes,
cytotoxicity ofhuman skin cells and the exposure ofbronchial cells to nanotubes.
Exposure ofhuman skin cells to unrefined nanotubes produced oxidative stress
(Shvedova et al.,
"Keratinocyte"
1924) and bronchial epithelial cells were adversely
affected through the mechanism ofoxidative stress when in contact with nanotubes
(Shvedova et al.,
"Bronchial"
91) whichmay lead to disease caused by the toxicity of this
material to the skin and lungs of exposed workers.
4.8 Target Organs
The target organs for inhalation exposures are the lungs and respiratory system.
Particles and aerosols larger than 5 micrometers (um) in diameter are captured in the
nasopharynx and tracheobronchial regions of the respiratory system. The main defenses
against particulates and aerosols in these upper regions of the respiratory system are
impaction and capture in mucous. The mucous covered airways of the tracheobronchial
region are where cilia rhythmically beat to move impacted particulates up and out of the
respiratory system in a bed ofmucous to the throat. Generally, particles less than 5 um,
especially 1 to 3 um size particulates, are deposited deep inside the lung in the pulmonary
(alveolar) regionwhere gas exchange occurs and macrophages work to remove impacted
particulates (Sobsey).
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Deposition ofultrafine particles within the three regions of respiratory system is
essentially size dependentwith
about 90% of inhaled UFP [ultrafine particles] around lnm
in size deposit in the nasopharyngeal region (Swift, et. al.
1992, Cheng et al. 1996 ), whereas only about 10% of this
size deposit in the tracheobronchial and essentially none in
the alveolar region; in contrast, 5 to 10 nm UFP deposit
equally in all three regions with about a 20-30% efficiency,
whereas 20-nm UFP are predicted to be deposited in the
alveolar region up to 50% and only about 10 % each in the
nasopharyngeal region and tracheobronchial regions (ICRP,
1994). (qtd. in G. Oberdorster et al.)
Nanoparticles or ultrafine particles, which deposit deep inside the lung in the alveoli,
are removed by macrophages which move to the site of impaction, engulf and carry the
particles up to the ciliary escalator or transport the particles through the lung interstitium
to the lymph system where they are carried to the lymph nodes.
Bothmechanisms tend to remove the particles from areas
where they have the potential to cause harm and to
neutralize their toxicity. However, an overwhelming dose
may lead to excessive inflammation, scarring (fibrosis) and
destruction of lung tissue, as exemplified by bacterial




Another target organ of concern is the skin. The skin, the largest organ of the body, is
made up of a thin outer layer (called the epidermis) and a thicker outer layer (called the
dermis). The dermis contains glands that produce sweat and the protective secretion,
sebum. The blood supply to the dermis layer
allows recruitment of inflammatory cells when the skin is
attacked by bacteria or otherwise damaged, enabling
protective inflammation and tissue repair. Prolonged or
repeated inflammation such as may be induced by certain





While nanoscale titanium dioxide does not penetrate viable skin, other nanomaterials are
known to move through the skin, because of that cosmetic products are being developed
to take advantage of this process. "Some toxicologists are alarmed by the trend. The
skin is a barrier for a reason - to keep harmful substances out. Ifnanoparticles can
penetrate will they end up in the bloodstream and brain? Will they do
damage?"
(Boseley). The answers to these questions have yet to be fully explored.
The ingestion ofnanomaterials and their effects on the gastrointestinal tractmay also be
an issue, but little research has been done on this with the exception of lead exposures
involving hand to mouth exposure and contamination of food stuff in certain industries
(Aitken, Creely and Tran 15). As a result, ingestion exposure is expected to be directly
related to skin exposure, food storage and personal hygiene practices in the workplace.
4.9 Physical Characteristics ofUltrafine/Nanoparticles
The physical characteristics ofultrafine particles are important to understand in order
to comprehend their interactions with target organs and cells. As previously stated,
nanoparticles approach the size ofmolecules and atoms. "They are smaller than human
cells (10,000 to 20,000 nanometers in diameter) and organelles and similar in size to
large macromolecules such as enzymes and receptors [. . .]Nanoscale devices smaller than







between organs for nanoparticles to move into and around the
body. These
'caveolar'
openings are thought to be involved in the transport ofproteins
and othermacromolecules around the body and are the correct size for transporting
nanoparticulates ("No Small Matter Annex").
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Also, because of their small size nanoparticles "account for amajor portion of the
numbers ofparticles within PM [ambient particulate matter], and have a high surface area
to mass
ratio"
(Brook, et.al. 2657). For example, "to obtain 10
ug/m3
[micrograms per
cubic meter] of2 um [micron] diameter particles you only need 1.2 particles per ml of air
and a total surface area of24
um2
/ml; the same airborne mass concentration of20 nm




Jefferson and Tilley state that it is the relatively high proportion of surface atoms that
makes these particles so interesting; for instance for a 50 nanometer single particle one in
six atoms will be at the surface (64). "Such a high proportion of surface atoms ensures
that, in general terms, nanoparticles of this size regime display vastly increased
reactivity"
(Jefferson and Tilley 64) because more atoms and theirmolecular bonds are
exposed and available for interactions with adjacent atoms. Thus the increased surface
reactivity coupled with the large numbers ofparticles and their large surface area to mass
ratio may account for the enhanced inflammation and other adverse effects observed from
exposure to these materials. In their conclusion Jefferson and Tilley state "we cannot
regard these nanoparticles as small crystals ofbulkmaterial, and the physical and
chemical properties of the latter can no longer
apply"
(81). They further state that
contrary to popular belief these are not crystalline in structure but are rather "large
inorganic macromolecules with molecular rather than crystalline
properties"
(82).
4.10 Health Effects ofUltrafine Particles
Ultrafine particles (less than 100 nanometers) are ubiquitous in the atmosphere arising
frommany different sources
- both man made and naturally occurring
- and have been
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implicated in causing respiratory and cardiovascular disease in susceptible subjects and
on a particle count basis account for the largest amount of ambient particulates (Brook,
et.al. 2657). Initially ultrafine particle exposures were generally confined to the work
place; however due to the increase in ambient concentrations of these particles,
toxicologists have explored the relationship between ambient exposure to these materials
and death and disease in susceptible populations. There has been a significant body of
work done on ultrafines and some of the information gleaned from these studies may be
useful in predicting the behavior and potential consequences of exposure to
nanomaterials where information on this subject is generally lacking.
Several factors were identified as determining particle toxicity ofultrafines. In the
case ofmineral dusts, the morphology (aspect ratio), surface area surface activity and
persistence in the body determine the toxicity of the particulate. "Whereas studies of
mineral dusts and asbestos have shown the importance ofparticle size, surface reactivity
and dose in the causation of lung disease, the most direct evidence on nanoparticles





most significant finding from research into air pollution particles for the hazard of
nanoparticles is that cells and organs may demonstrate toxic responses even to apparently




40). Studies ofultrafine particulates have
led to the general conclusion that the factors determining toxicity are
the total surface area presented to the target organ; the
chemical reactivity of the surface [including any surface
components such as transitionmetals and coatings], and
particularly its ability to take part in reactions that release
free radicals; the physical dimensions of the particle that
allow it to penetrate to the organ or cells or that prevent its
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removal: possibly, its solubility, in that soluble particles
such as salts may disperse before initiating a toxic reaction
("Nanoscience and nanotechnologies" 41).
4.10.1 Epidemiology
Epidemiological studies have shown that exposure to ambient airborne particulates is
associated with heart and lung disease, including atherosclerosis and cardiovascular
abnormalities and exacerbation ofbronchitis and asthma (Borm 316-31 8). It is likely
that a portion of the removal ofnanoparticulates from the lungmay be via the
bloodstream which then affects the cardiovascular system in general. Donaldson and
Stone hypothesize that there are two main ways that particulates can affect the heart. In
the first, the heart rate is changed electrically as the particles stimulate the autonomic
nervous system thereby stressing the heart or causing damage to the heart either directly
or indirectly. The second is that the particles affect the blood supply to the heartmuscle
causing increased "clotting, haemostasis and atheromatous plaque
rupture"
(Donaldson
and Stone 409) leading to ischemic stroke events.
There have also been observations linking cardiac events to increases in ambient
particulates. A recent letter from the CDC and FDA entitled "Nanoparticles Pose
Greater Cardiopulmonary Risk than
Thought"
addresses the health risk ofultrafine
particles. "Recent evidence in scientific literature suggests that a relatively small
increase in particulate matter of 1 0 micrometers or less [. .
.]
results in a small but





4). An American Cancer Society
cohort study estimated that for every increase in annual average exposure to 10
micrograms (ug) of fine particles (<2.5 wm) per cubic meter of ambient air, there is a
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6% increase in cardiopulmonary mortality rates (Brook et al. 2655). "Nanoparticles
behave aerodynamically like gas molecules and have a larger surface area, per unit
mass, than large particles. As a result, environmental nanoparticles can penetrate






In 1985, a severe air pollution episode occurred in Europe with elevated particulate
levels and other gaseous components. Higher than normal heart rates were observed in
the general population when adjusting for cardiovascular risk and weather. "An
elevated resting heart rate is a risk factor for death and fatal heart disease, andmay
signal changes in the autonomic control of the heart, that might partially account for the
adverse health effects observed in association with air
pollution"
(Peters et al. 1094).
Peters has suggested that an increase in blood plasma viscosity may account for this
effect whichmay modify the autonomic control of the heart at least contributing to the
adverse health effects seen.
Oberdorster's 2001 review entitled "The pulmonary effects of inhaled ultrafine
particles"
organizes various sources of information to make a case for the hypothesis
that ultrafine particles are a cause ofdisease in humans susceptible to their effects. The
reviewed studies, particularly those designed to mimic the characteristics of susceptible
portions of the human population, support the hypothesis that ultrafine particles are
responsible for the effects seen. "A number of epidemiological studies have
consistently shown an association of adverse effects on sensitive parts of the population,
with slightly elevated ambient particulate
pollution"
(1); the portion of the population
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identified as sensitive were elderly individuals with compromised cardiovascular and
respiratory systems.
4.10.2 Phagocytosis
The significantly larger surface area per unit ofmass ofultrafine particles versus
larger particles may also account for their increased effectiveness. "Thus although
inhaledmass concentrations ofultrafine particles may be very low, numbers ofultrafine
particles depositing in the alveolar region are extremely
high"
(G. Oberdorster 5).
Particles in the alveolar region are not as readily removed by phagocytes as well as larger
particles are. Renwick, Donaldson and Clouter found that ultrafine particles had a
greater negative impact on alveolar macrophage phagocytosis than did their fine counter
parts. The increased surface area, greater numbers ofparticles, the smaller sizes of the
ultrafine particles and the surface associated free radical generation [from both ultrafine
particles and phagocytes] may cause the impairment ofmacrophage phagocytosis
observed resulting in decreased clearance ofparticles from the alveoli leading to greater
concentrations ofparticles collecting in these areas (125).
Also, the smaller the inhaled particle, the more likely it was to reach the alveolar
surface of the lung and penetrate into the interstitium (Ferin et al. 383) from where it can
be transported through the blood stream or lymph system to other parts of the body. It
was found that effective phagocytosis prevents such penetration but that macrophage
breakdown or death "promotes translocation (ofparticulates) from the alveoli to the
interstitium"
(Ferin, et al. 383).
Evidence has also been found that the particulates work their way into the
interstitial lung space and are transported via the blood circulatory system to other
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locations within the body where they may cause harm. Preliminary studies done with
ultrafine platinum have found that approximately 8 % of the material introduced into the
lung found its way into the liver within 6 hours of exposure. However, there is some
question as to whether a portion of the platinum used in this study may have become
soluble and then filtered out by the liver (G. Oberdorster 5). Such studies point out the
potential for nanomaterials to cause damage to extra pulmonary organs when the route of
exposure is inhalation.
4.10.3 Inflammation
When compared on an equal mass to mass basis between fine and ultrafine particles
"the ultrafine particles produced free radicals to a much greater extent than their fine
counterparts"
(Renwick et al 125) due to the larger surface area of the ultrafine particles.
This oxidative stress is then transmitted directly to the lung tissue in contact with the
reactive particle. "Furthermore, reactive oxygen species are generated during




Additional studies ofultrafine platinum and carbon particles (-20 nm in diameter)
inhaled by healthy and emphysematous mice showed a very mild
pulmonary-
inflammatory response. However, using amodel of rats exposed to endotoxin or
lipopolysaccharide (LPS) to mimic the early stages of a respiratory tract infection,
ultrafine and fine titanium dioxide (Ti02) exposure "confirmed that only the ultrafine
Ti02, not the fine Ti02, induced a significant pulmonary inflammatory response which
was greater than the LPS or with ultrafine Ti02
alone"
(G Oberdorster 6). A similar
model used in a study with LPS and ozone demonstrated statistically "that ultrafine
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carbon particles have an inflammatory effect of their own and that co-exposure to LPS
and ozone increases the response even
more"
(G. Oberdorster 7).
These studies have demonstrated that ultrafine particles cause a greater inflammatory
response than do fine particles.
Surface properties (surface chemistry) appear to play an
important role in ultrafine particle toxicity. Contributing to
the effects ofultrafine particles is their very high
size-
specific deposition when inhaled as singlet ultrafine
particles rather than as aggregates. It appears also that
inhaled ultrafine particles deposited in the lung largely
escape alveolar macrophage surveillance and gain access to
the interstitium. Inhaled low doses of carbonaceous
ultrafine particles can causemild inflammation in rodents.
Age and compromise/sensitized respiratory tract can
increase the susceptibility to effects ofultrafine particles.
(G. Oberdorster 7)
"Inflammation plays a key role inmany diseases from Alzheimer's disease to heart





have shown that people who take non-steroidal anti-inflammatory drugs have a reduced
incidence of cancer (Roan F3). However, the direct link between inflammation and
cancer while thought to be obvious has only been proven recently. In two experiments,
researchers at the University ofCalifornia have deactivated a protein called I-kappa-B
kinase beta (IKK-beta) inside cells and stopped cancer progression in its tracks.
Apparently IKK-beta promotes inflammation and inhibits cell death allowing tumors to
grow in older cells. Many cancers of the digestive tract are involved with inflammation
but it's not clear that inflammation plays a role in other types of cancer (Lock 1 1 7). The
effect of the generation ofproinflammatory compounds by canines exposed to
chronically polluted air and its possible relationship to neurodegenerative disease such as
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Alzheimer's disease has also been hypothesized by researchers (Calderon-Garciduenas et
al. 534).
4.10.4 Pathways to the Brain
The transport ofmacromolecules from the bloodstream to the brain is thought to be
limited or regulated by the blood-brain barrier. Recent findings suggest, however, that
nanomaterials can get into the brain through the barrier or by other available pathways.
In one study, the metals nickel (Ni) and vanadium (V), characteristic ofMexico City's
urban air pollution primarily from the burning of fossil fuels, were found post mortem in
the brains of resident dogs. "There was a gradient in the concentration ofbothNi and V
going from higher concentrations in the olfactory epithelium to lower, but still detectable
levels in the frontal
cortex"
(Calderon-Garciduenas et al. 527) suggesting transport of
these materials through the olfactory neuron to the brain. Higher levels of these materials
were also found in the peribronchial lymph nodes suggesting transport of these materials
through the lung interstitium to the lymph system. The researchers state that this metal
uptake to the brain "could be through olfactory neurons and axons, peripheral sensory
nerves, direct passage of inhaled particles into the systemic blood circulation, and
through lung intravascularmacrophage-like cells that ingest ultrafine PM and are capable
of reaching the
brain"
(Calderon-Garciduenas et al. 532).
In a recent study by Oberdorster et al. published in July 2004 entitled "Translocation
of Inhaled Ultrafine Particles to the
Brain,"
evidence has been found that ultrafine
particles, particularly those on the lower end of the nanoscale, are readily taken up by the
olfactory bulb in rats and transported to the brain. The hypothesis for this study was
based on an earlier study where inhaled ultrafine particles ofCo were found to be
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concentrated in the olfactory bulb of laboratory rats. In a subsequent experiment C13
ultrafine particles were used with a central mean distribution of37 nm and 35 nm in
diameter. The investigators "found significant and continuous increases of C13 in the
olfactory bulb throughout the 7 day post-exposure period following a 6 hour inhalation
exposure to ultrafine elemental C13
particles"
(441 ). CB was also found in the cerebrum
and cerebellum (441). The investigators concluded "that inhaled ultrafine particles are to
a significant extent translocated to the CNS [central nervous
system]"
(444) via the
olfactory bulb and associated neurons "circumventing the tight blood-brain barrier. This
generally unrecognized clearance pathway from the nasal mucosa to the CNS could be of
significance for induction ofneurotoxic effects following acute or chronic inhalation
exposures to environmental or occupational UFP [ultrafine
particles]"
( 444 ). The
authors also state "it appears, therefore, that UFP size and chemistry (e.g., carbon vs.
metal) are important determinants for extrapulmonary translocation of
UFP"
(438).
4.10.5 Transition Metal Coatings
One ultrafine study ofnote, "Increased inflammation and intracellular calcium caused
by ultrafine carbon black is independent of transitionmetals or other soluble
components,"
was undertaken with the expressed purpose of determining whether
reactive compounds such as transition metals, which are thought to coat ultrafine
particles, or the particle itself, in this case ultrafine carbon black, are responsible for the
lung inflammation found in rats exposed to this material. Comparisons were also made
between ultrafine carbon black (UFCB), 4 nm in diameter and fine carbon black (CB),
320 nm in diameter, and each's ability to cause lung inflammation. In addition, sets of
each were coated with desferrioxamine mesylate (desferal) which deposits Fe (III) on the
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surface of the particles. The four types ofparticles were then instilled into the lungs of
rats. The results of the study indicated that the both types ofUFCB caused significant
lung inflammation versus both types ofCB. However there was not a statistically
significant difference in proinflammatory action between the treated and untreated types
ofUFCB. The authors concluded "the increased inflammogenicity of the UFCB
compared with CB cannot be explained by soluble transition metals released from or by
the accumulation of iron on the particle surface. Differences may be accounted for by the
increased surface area or particle
number"
(Brown et al. 685). These findings are in
direct contradiction from the findings ofMaynard, et.al cited below. Additional research
may be necessary in order to resolve the conflicting study results.
4.11 Nanomaterials
While the body of research on engineered nanoparticles is not as extensive as those on
ultrafine particles, significant strides have beenmade in identifying toxicity and health
effects as well as preliminary work on target organs and the anticipated routes of
exposure in the workplace. Basically similar health issues have been identified with
nanoparticles as those found with ultrafines.
The evidence suggests that at least some manufactured
nanoparticles will be more toxic per unit ofmass than
larger particles of the same chemical. This toxicity is
related to the surface area ofnanoparticles (which is greater
for a given mass than that of larger particles) and the
chemical reactivity of the surface (which could be
increased or decreased by the use of surface coatings). It
also seems likely that nanoparticles will penetrate cells
more readily than larger particles ("Nanoscience and
nanotechnologies"
4).
"The greatest potential for exposure therefore over the next few years will be in the





42). Also, according to the Royal Society and Royal Academy ofEngineers, a
substantial amount ofnanoparticles, such as those potentially found in the workplace,




Carbon nanotubes are an interesting prospect from a safety and health standpoint
because of their fiber-like characteristics (aspect ratio), low solubility in the lung and
extremely small size. Because of their fibrous shape, they have been described in the
popular press as the next asbestos and have been singled out as something to handle with
particular caution ("Nanoscience and
nanotechnologies"
4). Currently, there are two gas
phase synthesis production processes that have been partially investigated by researchers
interested in the health effects ofunrefined single walled nanotubes. Maynard et al.
investigated single walled carbon nanotubes and the potential for exposure during two
production processes, the laser ablation process and the high pressure carbonmonoxide
process (HiPCO) which were described in more detail in theManufacturing Processes
section above.
Materials produced by both processes end up with significant amounts of catalyst
metal in and on them and, therefore, would have to go through secondary processing to
remove the metals from the nanotube construct. Unfortunately, not all of the catalyst can
be removed without destroying a significant amount of the formed nanotubes. Both
processes end up with a "very low density material comprised ofnanometer-diameter
catalyst metal particles, carbon nanotubes and other forms of elemental carbon. This
material is manually handled prior to further processing, and has the potential to release
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Measurements were taken at the National Aeronautics and Space Administration
(NASA) Johnson Space Center in Houston, Texas at the laser ablation facility, and a
simulation ofmanual handing after the HiPCO process was carried out at Rice University
in Houston, Texas. Both processes were also simulated at CarbonNanotechnologies, Inc.
in Houston, Texas. The results of the study suggest "that respirable nanotube aerosol
generation from production powders is an inefficient
process"
(Maynard et al. 99). In
fact, while the laboratory studies do indicate that nanomaterials can be made airborne
with sufficient agitation, "the aerosol concentrations generated while handling unrefined
material in the field at the work loads and rates observed were very
low"
(Maynard et al.
106). These results indicate that, dependent upon agitation and disturbance of these
materials, exposure by inhalationmay not be a significant route of exposure.
However, there may be a significant dermal exposure risk. "Glove deposits of the
SWCNT during handling were estimated at between 0.2 milligrams (mg) and 6 mg per
hand"
(106). Also because large clumps of this material can become airborne and
although not considered to be respirable, the release of these materials may "lead to
dermal exposures in less well protected
areas"
(106).
Since the skin was identified as amain route of exposure to carbon nanotubes, studies
were designed which looked at the effect unrefined (prior to catalyst removal) single
walled carbon nanotubes had on the viability ofhuman epidermal keratinocyte (HaCaT)
cells. Since, as previously mentioned, iron and nickel are used as catalysts in each
manufacturing process, "the health risk associated with nanotube materials prior to the
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removal of catalyst is therefore likely to be associated with both the carbonaceous and
metallic components. Transition-metal complexes as well as free iron and nickel are





The results from this study indicate that the presence of iron (up to 30%) encased in the
carbonaceous structure of the unrefined SWCNT is associated with the adverse effects
observed on the keratinocytes in vitro. "Exposure of the HaCaT cells to the SWCNT
induced oxidative stress, which was confirmed by the presence of free radical species,
accumulation ofperoxidative products, reduction of lowmolecular weight thiols and a
decrease ofvitamin E and total antioxidant
reserves"
( Shvedova et al.
"Keratinocyte"
1922), which resulted in loss of cell viability. In addition to the loss of cells, "in vitro




"Additionally, exposure to SWCNT resulted in ultrastructural and morphological
changes in cultured human cells. Data indicate that unrefined SWCNT exposure can




1924). Thus, not only can the carbon based
nanotubes potentially have an adverse reaction on the skin cells, this effect can be
accelerated by the presence ofprocess catalysts in unrefined nanotube product.
Also, while inhalation is not recognized as amajor route of exposure, it may become
significant with enough disturbance of the unrefined nanotubes; as a result, the
researchers investigated the effects ofSWCNT on cultured human bronchial epithelial
cells. Again the investigators used unrefined SWCNT containing up to 30% iron. They
McShane 43
also state that they question an earlier finding from Brown et.al, 2000 "that transition





100). Using reducing agents to neutralize
the oxidative properties of the embedded iron, they found "remarkably reduced
cytotoxicity indicating redox active iron within the SWCNT matrix was primarily
responsible for SWCNT-induced cytotoxicity" (100). In the conclusion of this paper, the
authors call for further research to separate the cytotoxic effects of the transitionmetals
from those of the carbon nanotubes; thus more work on refined carbon nanotubes is
needed.
Nanotubes from other materials other than carbon are being developed. "Perceived




42). "Technology exists that allows
production ofnanotubes that can have remarkable predicted dimensions of a few
nanometres in diameter and micrometres in length [although currently they can only be




42). Because of their fibrous shape, ability to penetrate deep into the
lung, low solubility and the presence of transitionmaterials on the surface of these
constructs, nanotubes could present a significant hazard to workers ("Nanoscience and
nanotechnologies"
42). However, these constructs may tend to clump togethermake
their entrance into the deeper portions of the lung more difficult. "Little is known of their
aerodynamic properties and indeed whether they can present a risk in the air in sufficient






Presently, the production of individual nanotubes that do not bind together to form
clumps has not occurred. It is considered unlikely that these materials will be readily
made airborne anytime in the near future. However,
given previous experience with asbestos, we believe that
nanotubes deserve special toxicological attention [...] In
the meantime, we believe that there is sufficient concern
about possible hazards to those involved in research and





Fullerenes have the potential to act as drug delivery systems and also have been found
to have anti-oxidant effects. In order to make them biocompatible which would allow
them to reach certain target organs and cells, it is thought that the fullerenes or other
types ofnanoparticles would be bound with proteins or othermaterials to allow transport
within the body (Borm and Kreyling 2).
One study performed by Eva Oberdorster of Southern Methodist University
demonstrated that largemoufh bass showed brain damage when exposed to moderate
levels, 0.5 parts permillion (ppm), ofCarbon 60 (nC60) fullerenes. Fish exposed to a
0.5 ppm concentration of nC60 fullerenes showed "a significant increase in lipid
peroxidation in [. .
.]
exposed fish compared with controls. The difference between the
brain, gill and liver are striking. The gill and liver showed a trend toward decreased lipid
peroxidation, whereas the brain had significantly elevated lipid
peroxidation"
(E.
Oberdorster, 1060-1061). In addition to describing another instance of transporting these
materials to the brain, these findings raise questions about the environmental impact these
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materials will have and also ifhealth and safety issues will arise from exposure to these
materials as injectable therapeutic agents.
The toxicity ofwater-soluble polyalkylsulfonated C60 in rats by various routes of
exposure has also been assessed. Rats were exposed to polyalkylsulfonated fullerenes
(FC4S) using oral and injection (intravenous and intraperitoneal) routes of exposure. The
FC4S introduced orally were found to be non-toxic to the rodents. Both intravenous and
intraperitoneal injections ofFC4S, however, were eliminated through the kidneys, which
were damaged by the exposure causing phagolysomal nephropathy. The authors state
that the observed changes to the kidneymay serve as a biological marker of exposure in
toxicity tests for this class ofnanoparticles (Chen et al. 150).
4.11.3 Quantum Dots
Quantum dots are "semiconductor nanoparticles that can be
'tuned'
to emit or




3). While quantum dots can be used as
labels and assays without doing apparent harm to cells in-vitro, researchers at the
University ofCalifornia in San Diego have found that quantum dots can be cytotoxic
under certain circumstances. Quantum dots with a core of cadmium selenide capped
with a zinc sulfide (ZnS) or bovine serum albumin (BSA) coating proved to be toxic in
vivo. Toxicity was due to the release of cadmium ions from the cores of the quantum
dots when exposed to air and/or ultraviolet radiation. While the coatings were found to
inhibit the release of cadmium overall, enough was emitted to cause injury. "Long-term
ultraviolet (UV) exposure [to mimic phagocytosis] resulted in high levels of
cadmium-
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ion formation and cytotoxicity in hepatocytes (liver cells), even with an inorganic ZnS
and organic BSA capping layer, cadmium release still
occurred"
(Kalaugher 1).
4.11.4 Sunscreens and Cosmetics
Currently the general public is dermally exposed to nanoparticles through the use of
sunscreens containing nanoscale titanium dioxide particles. Iron oxide is used as a base
in some cosmetics as well. "It is clear that nanoparticles have different properties to the
same chemical on a larger scale, and the implications of these different properties for




43). In Europe, the Scientific Committee on
Cosmetic Products andNon-Food Products (SCCNFP) states that "titanium dioxide is
safe for use in cosmetic products at a maximum concentration of25 % in order to protect
the skin from certain harmful effects ofUV
radiation" ("Opinion"
1). The evaluation and
opinion from the SCCNFP in June of2003 for the use ofmicronized zinc oxide in sun
block and cosmetics requires further study ("The Scientific
Committee"
28). There is
insufficient information about whether other nanoparticles used in cosmetics (such as
zinc oxide) penetrate the skin, and there is a need formore research into this.
Ifnanoparticles penetrate the skin they might facilitate the
production of reactive molecules that could lead to cell
damage. There is some evidence to show that nanoparticles
of titanium dioxide (used in some sun protection products)
do not penetrate the skin but it is not clear whether the
same conclusion holds for individuals whose skin has been
damaged by sun or by common diseases such as eczema.
There is insufficient information about whether other
nanoparticles used in cosmetics (such as zinc oxide)






Nanoparticulates are thought to be the next vehicle for transporting therapeutic agents
to the proper organ or cells by injection of these materials into the body. However,
particulates smaller than 7 um are generally taken up bymacrophages of the liver and
spleen, and larger particles are trapped mechanically in the capillary network of the
lungs (Ilium et.al. 367). By selecting the proper biologically active coating for the
nanoparticulates, the scavenging of these materials by the liver or spleenmay be
reduced permitting the particle to be selectively transported to organs or cells of choice
depending on the coating type (Ilium, et al 368).
While the "Nanoscience and
nanotechnologies"
Report expresses concern for the
effects these materials would have on patients, the exposure to these materials
especially those that are coated with biologically active substances used to target certain
organs or cells would almost certainly present a hazard to those occupationally exposed.
The findings suggest that surface coatings may determine where these particulates may
end up in the body whichmay include less desirable locations such as the brain
("Nanoscience and
nanotechnologies"
41). Since the surface coating of the particle will
contribute (as may be the case of transitionmetals) or detract form the toxic response of
the material, investigation of specific nanoparticulates and/or their coatings for their
particular effects is warranted prior to worker being exposed to them. In particular,
nanoparticles created for biomedical purposes and designed to penetrate the body,
organs and cells through the use of surface coatings must be evaluated for their potential





While it is accepted and necessary practice to use laboratory animals as models for the
investigation ofhuman disease, it is also important to understand some of the different
responses to challenge each species typically displays. In particular the rat is considered
to be a very sensitive model when it is subjected to pulmonary challenge. "In the rat, the
time course and pattern of (particle) accumulation, chronic inflammation, epithelial
hyperplasia and tumourigenisis are essentially the same for all particles [...] The potential
for tumors (to develop) is especially marked when particles are in the ultrafine
mode"
(Klaassen 998). Inflammation is not as great in the mouse and hamstermodel and thus
tumorogenesis is not as marked. Warheit states that the rat model is very sensitive to




So while the rat and other species are considered to be acceptable models ofhow the
human body will react to a specific challenge, there is no guarantee that the human
response will be identical or even similar to the animal model. Instilling high doses of
particulate matter into the lung is also a relatively common method ofdelivering
particulates to the lung. "In long term high dose inhalation studies in animals, the
chronic effects produced by ultrafine particles include inflammation, increased
chemokine expression, epithelial hyperplasia, pulmonary fibrosis and lung tumours.
However these effects are a consequence of
overload"
(Brown et al. 685). The overload
model is considered to be an extreme case of exposure and does not reflect typical
exposure episodes found in the workplace.
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4.12 RiskAssessments
"The purpose of a risk assessment is to provide pertinent information to risk
managers, specifically, policy makers and regulators, so that the best possible decisions
can be
made"
(Paustenbach 4). The United States Environmental Protection Agency
(EPA) defines a risk assessment as a four step process: hazard identification, exposure
assessment, dose-response assessment and risk characterization ("Risk Assessment for
Toxic Air Pollutants").
The first step is hazard identification or what health problems can be caused by an
exposure to amaterial ("Risk Assessment for Toxic Air Pollutants"). According to the
National Academy ofSciences, hazard identification involves determining whether
human exposures to a particular agent will "cause an increase in the incident of a health
condition (cancer, birth defect,
etc.)"
(Paustenbach 7). The National Research Council
states that these hazards are identified through toxicological experiments with
laboratory animals, and rarely is there adequate and definitive data from health effects
on humans (Paustenbach 7).
The second step is exposure assessment or howmuch of these materials are people
exposed to over a given time period ("Risk Assessment for Toxic Air Pollutants").
"Exposure assessment measures or estimates the intensity, frequency, and duration of
human or animal
exposure"
(Paustenbach 9) to a particular agent.
Step three involves a dose response assessment or what health problems are
associated with different exposure concentrations and the various routes of exposure
("RiskAssessment for Toxic Air Pollutants"). "Dose response assessment is the
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process of characterizing the relationship between the dose of an agent administered or
received and the incidence of an adverse health
effect"
(Paustenbach 7).
Finally, the risk is characterized several different ways to describe how exposure to a
particular contaminant will increase the risk to one's health ("Risk Assessment for
Toxic Air Pollutants"). "Risk characterization is the process of estimating the incidence
of a health effect under the various conditions of human or animal
exposure"
(Paustenbach 9).
Currently there is not enough data available to make a definitive statement about the
risks that nanomaterials will pose in the workplace. It is expected, however, that some
nanomaterials may be characterized as hazardous while others may not be. Much work
has been done on the health hazard side of this issue in laboratory animals and through
epidemiology studies ofhuman populations with ultrafine, butwork is just beginning
with hazard identification and effects on target organs as they relate to particular routes
ofexposure associated with nanomaterials. Currently the other steps in the risk
assessment process have not been addressed to any acceptable degree. "Research into
the hazards and exposure pathways ofnanoparticles and nanotubes is required to reduce
the many uncertainties related to their potential impacts on health, safety and the






While amoratorium on work with nanomaterials will not occur, there appears to be a
consensus among stakeholders that some sort of regulatory framework is necessary. In
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order for there to be meaningful and effective regulation there must be reliable
information on risk and the potential health effects of these materials.
In Europe the NANOSAFE project has been initiated to investigate the risks of
occupational exposure to nanoparticles. The United Kingdom's Task Force on Better
Regulation warned in 2003 that nanotechnology safety regulations were needed.
The Task Force also outlined five necessary principals for effective regulation. They
are:
Proportionate: Regulators should only intervene when necessary.
Remedies should be appropriate to the risk posed, and costs identified and
minimized.
Accountable: Regulators must be able to justify decisions, and be subject
to public scrutiny.
Consistent: Government rules and standards must be unified and
implemented fairly.
Transparent: Regulators should be open, and keep regulations simple and
user friendly.
Targeted: Regulation should be focused on the problem, and minimize
side effects. ("Principles ofGood Regulation")
This Task Force was also responsible for initiating the "Nanoscience and
nanotechnologies"
Report from the Royal Society and the Royal Academy of
Engineering. The conclusions within this report state that they do not support a full
moratorium on nanotechnology. The Academies recommend that regulators work within
their own existing regulatory frameworks to address potential issues and use a
precautionary framework to address knowledge gaps ("Nanoscience and
78). Indeed, "with real nanotech products already on the marketplace,
and a deluge to follow, an urgent set of issues revolve around the adequacy of our
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existing regulatory system to provide the necessary safeguards and early
warnings"
(Wardak 1). The Academies also recommend that the UK Research Councils
assemble an interdisciplinary centre (perhaps from existing
research institutions) to undertake research into the toxicity,
epidemiology, persistence and bioaccumulation of
manufactured nanoparticles and nanotubes, to work on
exposure pathways and to develop measurement methods.
The centre should liaise closely with regulators and with
other researchers in the UK, Europe and internationally.
("Nanoscience and nanotechnologies" 5)
NIOSH has recently begun to develop the NIOSHNanotechnology Research Center
which will coordinate all agency-wide nanotechnology activities. Additionally, the
NIOSHNanotechnology and Health & Safety Research Program, "which is a five-year
multidisciplinary study into the toxicity and health risks associated with occupational
nanoparticle
exposure"
("NIOSH Safety and Health Topics") has just recently been
initiated.
In October of2004 the First International Symposium onNanotechnology and
Occupational Health was held. This is a cooperative effort between the United
Kingdom and the United States where what is known and what needs to be known
about nanotechnology will be discussed to enhance workplace safety ("NIOSH Safety
and Health Topics").
A search of the Occupational Safety and Health Administration (OSHA) website did
not produce any information on nanotechnology and its risk. When the local OSHA
area office was contacted by Rice University concerning guidance for safely working
with nanomaterials, the area office supplied a copy of the chemical hygiene standard,
CFR 1910.1450, "Occupational exposure to hazardous chemicals in
laboratories"
(Kulinowski). Presumably this regulation and OSHA's general duty clause will be the
McShane 53
mechanisms of enforcement for research laboratory and manufacturing facilities
providing that these nanomaterials are classified as hazardous.
The EPA through its Science to Achieve Results (STAR) grant program has allocated
approximately $6 million to support 16 universities in their efforts to study this
emerging technology. While the research concentration is on the use of this technology
for environmental remediation, the EPA does recognize that there may be some
detrimental environmental issues associatedwith the use ofnanomaterials. "Alongside
the vision ofnanotechnology that could lead to big advances in environmental
protection are questions related to the potential environmental concerns that could be
associated with this new
technology"
("EPA Research and Development"). Also,
through the Toxic Substances Control Act (TSCA) "the EPA has the power to prohibit
and or limit the manufacture ofparticular chemicals based on risk
assessments"
(Wardak 3). So while OSHA usually regulates chemical exposure in the workplace "the
EPA has used TSCA as a means for exercising its own regulatory authority to minimize
workplace
exposures"
("How the Small World of
Nanotechnology"
4).
In the UK the recent "Nanoscience and
nanotechnologies"
Report states that the
present regulatory frameworks in European Union and United Kingdom are "broad and
flexible
enough"
to handle nanotechnology development at this point, but further work is
needed to be done to determine ifnew regulations are required or existing ones need to be
modified to accommodate the Precautionary Principle (6). The Academies further state
"We recommend that the Health and Safety Executive carry out a review of the adequacy
of existing regulation to assess and control workplace exposure to nanoparticles and
nanotubes including those relating to accidental release. In the meantime they should
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4.14 Application of the Precautionary Principle
According to the NANOSAFE initiative there will be a dramatic increase in the
manufacture ofnanoparticles. As a result, there is likely to be an increase in significant
exposures to the worker populations within affected industries as well as an increase in
health effects from those exposures unless work is carried out to address this problem
("Risk Assessment ofAirborne
Nanoparticles"
1). It is the author's contention that given
the recent information generated from preliminary toxicological and exposure assessment
studies and previous work performed with ultrafine particles, there is ample reason to
proceed cautiously when working with nanomaterials. It is acknowledged that the
evidence is by no means definitive, but it does suggest that there are hazards associated
with exposures to nanoparticles and nanotubes. Given the fact that exposures to these
materials will be increasing as this technology insinuates itself into various types of
industries, it would be prudent to adopt the Precautionary Principle and treat
nanomaterials as if they are hazardous to ensure worker safety until research provides
information that justifies relaxing these precautions. To paraphrase Paul C. Lin-Easton,
the Precautionary Principle states that decision making in extreme uncertainty should not
be delayed due to the lack of information in matters that concern environmental threats.
Applying this reasoning to occupational health and safety would not only benefit
personnel exposed to these potentially hazardous materials but it would also reduce
potential liability issues as well as worker compensation and insurance costs in affected
industries.
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While the hazards associated with the types of conventional chemicals and physical
processes used to make nanomaterials have been well characterized and risk assessments
could be reasonably completed in an accurate fashion, there is not enough information
available to make reasonably accurate risk assessments ofnanomaterials themselves.
Since characterization ofharmful properties is paramount but the necessary information
is not available, precautionary measures must be taken and the materials assumed to be
toxic until proven otherwise. "Specifically, we [The Royal Society and Royal
Engineering Society] recommend as a precautionary measure that factories and research
laboratories treatmanufactured nanoparticles and nanotubes as if they were hazardous





The Health and Safety Commission of the United Kingdom
states that the defining characteristic ofnano-scale
materials is that they are very different from their macro
scale counter parts due to physical, chemical and bio
chemical differences in properties. Because of the lack of
knowledge concerning the properties of these materials
there is considerable uncertainty in any assessment of
health and safety risks[. . .] Similarly there may be a lack of
knowledge about the effectiveness of risk control measures
[. .
.]
All modern health and safety legislation is based upon
the principle of suitable and sufficient assessment of the
risks leading to the implementation ofproportionate
preventative and protective measures. Proportionate in this
context means erring on the side of safety [. . .] It
allows for
uncertainty both in the risk
assessment and in the
effectiveness of the control measures
- the greater the
uncertainty the more precautionary
the duty holder needs to
be. (Davies 2-3)
4.15Workplace Controls
While production ofvarious nanoscale materials continues and is increasing, there is
virtually no information available in the literature on reducing
exposure to
nanomaterials in the workplace. It is important to note that in nanotechnology research
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and development laboratories and manufacturing facilities additional hazards are
typically posed by the conventional hazardous materials that must be used to create
nanomaterials. The various types ofmaterials include hazardous chemicals in liquid,
solid and gaseous form that may be oxidizers or flammable, corrosive, toxic or
biological in nature. Presumably these exposures will be addressed through OSHA
regulations including Hazard Communication CFR 1910.1200, Chemical Hygiene CFR
1910.1450 and Process Safety CFR1910.1 19.
At a recent Tradeline Conference held in August 2004, specific chemicals mentioned
as being necessary for R& D work with nanomaterials include pyrophoric materials
such as the compressed gas, silane. Flammable liquids are also used in open systems
including acetone, benzene, butyl acetate and alcohols. Flammable compressed gases,
including hydrogen, methane, dichlorosilane, carbon monoxide and ammonia, are used
to process these materials. Oxidizing compressed gases such as chlorine, fluorine,
nitrogen trifluoride, oxygen and nitrous oxide are also used. Corrosive liquids,
including hydrochloric acid, hydrofluoric acid, nitric acid and other photoresistive
strippers, are also used in open systems. Corrosive solids such as potassium and sodium
hydroxide were also mentioned. Significant amounts of toxic materials including
developers are also used (Case and Grant). In addition to these chemical hazards, there
will also be physical hazards associated with this work including the previously
mentioned high pressure gas, lasers and associated hot plasmas.
The question ofwhat types of equipment will work to protect personnel from
nanomaterials has yet to be completely answered, but such controls will most likely be
found in the accepted hierarchy ofprotection. The methods of controls will include
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engineering and administrative controls and, as a last resort, personal protective
equipment. Interestingly the "Nanoscience and
nanotechnologies"
Report from the UK
does not emphasize the use of engineering controls but states "that workers should seek
protection by the usual methods of industrial hygiene, including the provision for
respiratory protection and appropriate hazard information, togetherwith appropriate
procedures for cleaning up accidental emissions and formaking repairs to machinery
("Nanoscience and
nanotechnologies"
42). The UK Health and Safety Commission
also emphasizes the use of appropriate respiratory protection including the use of self
contained breathing apparatus should the situation warrant it (Davies Annex 1).
Perhaps the reason for the emphasis on PPE and respiratory protection is because
there is no information available on proper containment for these materials. Additional
considerations may be the generation of air currents, vibrational forces, electromagnetic
radiation (Rossrucker) and any other potentially disruptive forces thatmay make
working with nano-scale materials difficult or impossible. Therefore itmay be
necessary to invent new and innovative containment equipment to address these issues.
Additionally, standardized and validated methods formonitoring occupational
exposure must be developed to monitor levels of these materials in the workplace and
academic institutions. Efficacy testing of filtering materials for engineering controls
and respirators is needed as well ("Nanoscience and
nanotechnologies"
42).
On December 18, 2003 a panel of grantees from the National Science Foundation
met to discuss issues related to environmental safety and health best practices. The
panel essentially made use of existing regulation and guidance to compile a list of
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general precautions designed to reduce or eliminate occupational exposure to
nanoparticulates. This document is in draft form.
The panel recommends a strong chemical hygiene plan to handle conventional
chemicals, an effective biosafety program and a strong training program. General
statements are also made concerning proper engineering controls to minimize exposure
as well as personal protective equipment to minimize inhalation and dermal exposures.
At the organizational level, the program should be overseen by the EHS Department
and actively monitored by the Safety Committee through audits. The EHS program
must also be backed up by top management.
The National Science Foundation document follows the OSHA recommendations for
amodel safety program ("Draft Proposed Safety and Health Program Rule"). However,
what is lacking in this document is specific information on what will actually work to
prevent exposure to these materials in the workplace.
Research on high efficiency particulate air (HEPA) filtration addresses some specific
questions relating to the size ofparticles that are efficiently removed by this process.
The size range of the particles tested were from 0.0032 um (3.2 nm) to 1.0 um. The
particle size found to be most penetrating with an Oshitari SO HEPA filter was in the
range of 0.1 to 0.18 um (100 to 180 nm) at the manufacturer recommended air flow rate
of2.4 centimeter/second (Yamada et al. 547). Removal efficiencies were greater in the
ranges above and also below this particle size range. The results infer that a least some
size ranges ofnano-scale materials may be captured but no statements on collection
efficiencies ofnanomaterials were made as this was not the researcher's primary focus.
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OnAugust 23, 2004 Vincent Castranova, Ph.D., Nanotechnology Safety and Health
Research Coordinator forNIOSH was interviewed concerning the viability ofusing
HEPA filtration for work with nanomaterials. Dr. Castranova stated that HEPA filters in
theory should work for containment ofnanomaterials but that more research needs to
done to verify this. When you get down to the size scale ofnanoparticulates the mass of
the particles is so low that particle inertia for impaction andmechanical capture is not
significant. Nanoparticles are so small that they move by diffusion and Brownianmotion
rather than through inertial forces as do larger particles which have more mass. For
diffusion to work and trap particles in the filter, the particles must have sufficient dwell
time in the filtermedium. Thus, if the flow rate of contaminated air through the filter is
too high the removal efficiency ofnanoparticles should decrease.
While not being able to definitively state what would work for the capture of
nanoparticulates, Dr. Castranova did relate what doesn't work. Misuse of impaction
filters can actually increase the release ofultrafine particles from a contaminated air
stream such as diesel exhaust, and this may also apply to the misuse ofHEPA filters.
Researchers found that using a paper filter to trap particulates at the exhaust outlet of a
diesel engine actually increased the availability of free ultrafine particles because the fine
particles in the exhaust stream were filtered out by the paper and were not available to
agglomerate and capture the ultrafine particles.
Since the size of nano-scale materials approach those of gas molecules, the question
was posed ifother types ofmedia for trapping these materials, such as activated carbon
which works by adsorbing contaminates on its surface, or if electrostatic precipitation
would work. Dr. Castranova did state thatmany of the types ofnanoscale particles have
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significant surface charges but that it is too premature to make any blanket statements
about what works and what doesn't. A more recent e-mail correspondence with Dr.
AndrewMaynard, an ultrafine particle expert withNIOSH, also verifies that controls
knowledge is still theoretical and further investigation is required ("RE: Nanotechnology
Thesis"). NIOSH is currentlyworking on many of these issues.
4.16 Explosive Dusts
The generation of combustible dusts is also a potential problem with these materials.
"Any dry, fine and combustible powder poses an explosion risk, either through
spontaneous combustion or ignition. The increased surface area ofnanoparticles might




47). Given their vanishingly small size, these
particulates will not be readily visible even in dense concentrations and therefore may not
be easily detected as potential explosion hazards. According to the "Nanoscience and
nanotechnologies"
Report there is no information available concerning this potential
hazard which could be significant in manufacturing facilities. The Academies
recommend that the dusts be handled in liquid. "The risk of explosion can be avoided if
combustible powders are manufactured, handled and stored in liquid. By contrast, the




47). The bottom line is that there may be an increased risk of
explosion because of the increased surface area available from nanomaterials and
potential for enhanced reaction. "Until this hazard has been properly evaluated this risk







5.0 Results and Discussion
5.1 Thesis Questions
The following research questions were asked
1.) What is the current state ofknowledge concerning occupational exposure risk
associated with nanotechnology?
2.) What are the areas of agreement and disagreement concerning nanotechnology in
the literature and among the experts, and what additional research is required to
generate a more complete picture of the health and safety problems surrounding
the issue?
3.) What occupational safety precautionary recommendations can be made for
research laboratory staffbased on the current state ofknowledge concerning the
occupational risks ofnanotechnology?
The primary research question asked by the author concerning the health effects of
exposures to nanomaterials is important for several reasons. There are good indications
that several types ofnano-scale materials are significantly more toxic than their larger
particle counterparts made of identical elements, meaning that by virtue of their size they
present significant health and safety hazards. In fact, relatively inertmaterials have
significantly increased toxicity as particle size decreases and relative surface area per unit
ofmass increases. Nanoscale materials have a larger and more reactive surface area by
virtue of the significantly greater number ofparticles necessary to equal the same mass of
larger diameter particles. Additionally, because of their size, they can readily penetrate
various organs and circumvent body defense systems potentially causing disease.
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Currently the workers primarily exposed to nano-scale materials are in the research and
development field as well as those inmanufacturing facilities.
The amount of individuals exposed is expected to increase, perhaps exponentially, as
the technology takes off as anticipated. It is extremely important that the risks involved
with these materials be thoroughly understood so appropriate controls can be put in place
to prevent injury to workers. Based on the merit of information found in the literature
review, a set ofhypothetical precautionary recommendations are included as well as two
standard operating procedures for workingwith free nanomaterials in the research and
development arena. The control technologies include the use of engineering controls
such as local exhaust ventilation and personal protective equipment to ensure worker
safety.
Due to the lack of information on the safety and health risks ofnanomaterials, it was
anticipated that there would be a significant amount ofdisagreement on the safety of
nanotechnology among the experts in the field. Only minor disagreements were found
within the scientific community related to specific details of study results such as the role
transitionmetals play in lung inflammation. While the question of the occupational risks
ofnanomaterials is being definitively answered, precautionary measures are
recommended forwork with all nanoscale constructs in the interim.
While no complete risk assessment information was found for nanomaterials, there
appears to be a general agreement within the academic, industrial and regulatory
communities that there is a need formeaningful regulationwhichwill provide a safe and
healthful work environment balanced with the need for rapid innovation. The question is
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what degree ofregulation is necessary. A review ofpublished opinions from experts
representing these stakeholders has confirmed this.
The original intent of this thesis was to review the literature and contact experts
concerning the risks ofworking with nanoparticulates and nanotubes in the occupational
setting and use this information to form a set ofprecautionary practices to work safely
wit these materials. However, the information on the risks associated with working with
these materials is either extremely preliminary or non-existent and, as a result, a full risk
assessment is not possible at this point in time. Also due to this lack ofdata, safe work
practice information recommendations can only be made on the basis of the
Precautionary Principle, which in this case means to treat all uncharacterized
nanomaterials as hazardous substances until proven otherwise. A precautionary approach
using the attributes of existing exposure control systems has also been included in this
document.
5.2 Background
Nanotechnology is a relatively new field that is expected to have huge potential to
impactmany different fields of technology. The field
has evolved very rapidly due
primarily to the development ofother tools
that have permitted the visualization and
manipulation ofmaterials on the scale ofmolecules and atoms. While the impacts are
expected to be positive in virtually all cases, there has been growing
concern from a
safety and health standpoint that exposures to
free or unfixed nanoparticles may pose a
risk to those working in research laboratories and manufacturing. Many
nanotechnologies pose no new risks to health, and almost all the concerns relate to the
potential impacts ofdeliberately manufactured nanoparticles and nanotubes that are free
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rather than fixed to or within an embedding material ("Nanoscience and
nanotechnologies"
4).
It is the properties of the nanomaterials which are primarily a function of their size
that set them apart from othermaterials. At the macromolecular level in which these
constructs exist "quantum effects can begin to dominate the behaviour ofmatter at the





2). For instance, carbon
nanotubes exhibit unusual quantum properties which can serve as wiring formolecular
computers at scales of size so small that ordinary electrical current flow is not possible
(Akin 3). Concerns have been expressed that the very properties ofnanoscale particles
being exploited in certain applications (such as high surface reactivity and the ability to
cross cell membranes) might also have negative health and environmental impacts.
53 Health Effects
Exposure to nanoscale materials is not something new; humans have been exposed to
nanoscale particulates from the products of combustion since fire was harnessed. While
past studies have focused on workplace exposures to ultrafine particles, recently it has
become apparent that ambient exposure to ultrafine particles in the atmosphere has
resulted in significant increases inmortality in susceptible portions of the population (G.
Oberdorster l).
The results from studies ofnanomaterials are preliminary. The ultrafine particle
studies are more numerous but require a more thorough characterization of the
toxicological, dose response and potential exposure issues posed by these materials.
However, while the routes of exposure have not been adequately identified and
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definitively defined for nanotubes, fullerenes and nanoparticulates in general, several
general statements can be made about potential exposures to these materials through
analogy to ultrafine particles for which there exists much more information on their
effects on laboratory animals and also on humans through epidemiological studies.
While technically they are not manufactured as nanomaterials are, inmany cases they
ultrafine particles similarmorphology, behave similarly aerodynamically andmay
undergo similar processes within the body. These particles are thought to enter and
reside in the body in the same way as nanoparticles and may be metabolized in a similar
fashion to nanoparticles.
Ultrafine particles were found to be more reactive than comparable amounts of larger
particles for several reasons: the greater surface area of the materials, the surface
characteristics of the particles themselves and the ability of these materials to move
relatively freely into and within the body or penetrate deep enough into it, as in the case
of alveolar deposition, to cause disease ("Nanoscience and
nanotechnologies"
41). Since
nanoparticles can also penetrate cells, they may also interfere with phage motility and the
ability of theses cells to clear the alveoli ofdeposited particulates
and bacteria. (Renwick,
Donaldson and Clouter 125).
If these particles are not cleared by phagocytosis when deposited deep in the lung,
they can penetrate the interstitium and be actively
transported throughout the body by the
circulatory system or lymph system (Ferin et al. 383; G. Oberdorster 7). In the short
term, these exposures can cause decreased pulmonary function, increased incidents of
cardiac events and inflammation (Brook et al. 2666, Donaldson and Stone 409). Chronic
inflammation has been shown to promote other diseases such as cancer (Lock 1 17).
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The hazards of these materials to specific segments of the population involving those
with impaired pulmonary functions has also been documented and can be further
acerbated by exposure to endotoxin and/or ozone which were found to have a synergistic
inflammatory response when coupled with ultrafine particle exposure to affected tissues
(G. Oberdorster 6). Additionally, ultrafine particles, particularly those at the lower end
of the nanoscale, were found to circumvent the blood brain barrier via the olfactory bulb,
potentially causing neurotoxic effects by inducing inflammation whichmay result in
neurodegenerative diseases such as Alzheimer's or promote cancer (G Oberdorster et al.
444; Calderon-Garciduenas et al. 386). Thus, it can be extrapolated using the preliminary
nanomaterials exposures in lab animals and ultrafine particle research that nanomaterials
may pose a significant and possiblymuch different occupational risk to workers in
research andmanufacturing than what has been seen before.
Inhalation was found not to be a significant route of exposure for unrefined single
walled carbon nanotubes (SWCNTs). However, should they be significantly disturbed,
they may become airborne and present an inhalation and surface contaminant risk. It was
found that there may be a significant dermal risk of exposure to nanotubes that may
deposit on surfaces significant distances away from the point of generation whichmay
"lead to dermal exposures in less well protected
areas"
(Maynard et al. 106 ). The
unrefined SWCNTs with significant amounts of transitionmetals present were also found
to be toxic to human dermal cells (Shvedova et al.
"Keratinocytes"
1924). The
mechanism of toxicity involved the creation of free radicals which oxidized the exposed
cells leading to inflammation, a promoter of some forms of cancer (Lock 117).
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SWCNT do pose a potential hazard causing respiratory tract inflammation ifmade
airborne and inhaled. Using SWCNTs containing up to 30% iron and
"neutralized"
or
reduced unrefined SWCNTs with human bronchial epithelial cells, researchers found
diminished cytotoxicity from the reduced SWCNTs indicating that the transition metal
catalystmay be primarily responsible for the observed cytotoxicity in direct contradiction
to an earlier study by Brown, et al. (Shvedova et al.
"Bronchial"
100). In the study
performed by Brown et al. ultrafine carbon black particulates (UFCB) were found to be
more proinflammatory than fine carbon black particles (CB). However, there was no
statistically significant difference found between the UFCB coated with the reactive
transitionmetal Fe(III) and uncoatedUFCB (690). Future studies are required to
separate the cytotoxic effects of the transitionmetals from those of the carbon nanotubes.
The health effects ofwater-soluble, polyalkylsulfonated C60 fullerenes (FC4S) in rats
were also investigated. It was establish that for rats ingestion of thesematerials is not
harmful; however, injection, intravenously or intraperitoneal, eventually will cause
damage to the kidneys as the fullerenes are metabolized (Chen et al. 150).
Quantum dots made from cadmium were found to be toxic when surface coatings
break down and a portion of the metal is released (Kalaugher 1). Based on the limited
evidence gathered, some nanomaterials may pose a significant health and safety risk to
humans through exposures to free nano-scalematerials in the occupational setting.
5.4Manufacturing
It has been determined that there is potential for exposure to agglomerated
nanomaterials in all four of the manufacturing processes identified: the gas-phase, vapour
deposition, colloidal and attrition processes "whichmay potentially result in exposure by
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inhalation, dermal or ingestion routes. . . during recovery, powder handling and product
processing"
(Aitken, Creely and Tran 57). Of the fourmanufacturing processes "only the
gas-phase processes have the potential to cause exposure to primary nanoparticles by
inhalation during the synthesis
phase"
(Aitken, Creely and Tran 57).
The full potential ofnanotechnology has not been fully realized yet because of
difficulties inmanufacturing a standardized product whether of a particular particle size
or a discrete uniform unit ("Nanoscience and
nanotechnologies"
3). Inmost applications
nanomaterials are usually embedded in amatrix, for example titanium dioxide added to
glass to make itmore dirt resistant or nanotubes embedded in car bumpers to add
strength. It is expected that the likelihood ofnanoparticles or nanotubes being released
from products in which they have been fixed or embedded (such as composites) is low
("Nanoscience and
nanotechnologies"
4), "but in some, such as those used in cosmetics




3 ). It is these free nanomaterials that pose the
greatest risk of adverse exposure not only as consumer products but also further up the
pipeline during manufacture and processing of these materials and initially as exposure
issues in the research and development laboratory.
Presently there is relatively limited manufacturing capacity available for the
production ofnanomaterials. It is imperative at this point in time that regulators address
this issue so that there is a uniform method for identifying hazardous properties of these
materials and communicating this information to the end user
and the public. Theymust
also develop effective controls to limit exposures and ameans to effectively promote
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compliance in a flexible manner to allow for the innovation and growth necessary for the
state of the technology and its control to stay current.
5.5 Regulation
Currently there are no regulations in place in the United States or any portion of the
world that specifically address the unique issues nanomaterials present. Additionally,
they have not been characterized as hazardous materials at this point in time. Within the
United States there is not even a regulatory requirement to test nanomaterials for health,
safety and environmental impacts ("Nanotechnology Safety Assessment").
The United States Environmental Protection Agency (EPA) defines risk
assessments as a four step process: hazard identification, exposure assessment, dose-
response assessment and risk characterization. Unfortunately, the only portion of this
process currently being addressed is step one, the identification ofpotential health
problems associated with exposure to these materials. A preliminary portion of the dose
response assessments has also been done concerning the effects these materials have on
target organs. This work will eventually lead to characterization of the routes of
exposure for nanotubes, fullerenes, quantum dots and other nanoparticulates. The
majority of the studies completed are associated with exposures
of laboratory animals to
nanomaterials either in simulated exposure scenarios or through direct instillation of
these materials to the animals. The more extensive body of literature on ultrafine
particles primarily includes lab animal exposures and also epidemiological surveys of
ambient exposures to pollutants.
It will be years before scientifically meaningful information will be available to
perform a rigorous risk assessment. Only recently have safety and health initiatives such
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as NANOSAFE from the European Union been launched, and it will be several years
before such initiatives bear fruit. Additionally, in the United States, the National Institute
ofOccupational Safety and Health (NIOSH) is currently embarking on a 5 year initiative
to research the potential hazards associated with nanomaterial exposures in the
workplace.
5.5.1 A Regulatory Scenario
In the United States, the EPA is given broad discretion through the Toxic
Substances Controls Act (TSCA) of 1976 (40 CFR 720.36) "to gather health/safety and
exposure data on, require testing of, and control exposures and/or use of, new and





37). TSCA, however, contains loopholes and exemptions
allowing producers of these materials to circumvent this regulation (Wardak).
The first step in the regulatory process should be the assignment of a unique Chemical
Abstracts Systems (CAS) number to each new or existing nano-scale construct. This
system provides the first early warning mechanism to the EPA that a new chemical
material exists (Wardak). However, as the system is currently set up, it may not catch all
nano-scale substances. Use of this system is currently not mandatory for proprietary
substances, also and there are exemptions for research and development. Parent
compounds may already be registered or comprised of inert
materials on the macro-scale
allowing the more toxic nanomaterials made of
the same elements escape surveillance. It
is recommended that the regulation be modified to capture all constructs below a certain
size in one dimension, for instance. Once a compound has the CAS number and is
manufactured or imported into the United States TSCA will most likely apply.
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Slightly modifying the language of the Toxic Substances
Control Act (TSCA) provides a reasonable starting point
[. .
.]using
TSCA as amodel, anyone wishing to
manufacture a new chemical must give prior notice to the
EPA for review under the pre-manufacturing notice
requirement. In the face of civil and criminal penalties (as
in TSCA) most firms and researchers would comply with
the notification requirements. (Forrest 7)
Once a pre-manufacturing notification (PMN) is received, within 90 days risk
managers within the EPA draw upon existing information submittedwith the PMN form,
research for other information and look at exposure and release models to form a
conclusion about the risk this material may present. When sufficient toxicity information
is not available to properly characterize a substance, more data will be requested by the
EPA through itsNew Chemicals Program ("Assessing Risk").
Section 5(e) ofTSCA provides authority to the EPA to regulate chemicals that are
lacking safety and environmental risk data based on the potential risk, on the basis of
substantial production volume, significant/substantial exposure to humans or
significant/substantial releases to the environment
("TSCA"
5(e) 1). Such regulation
could lead up to an outright ban of a
substance but generally if a PMN substance may
present an unreasonable risk to human health via and typically through inhalation, a
TSCA section (e) consent ordermay be issued in which aNew
Chemical Exposure Limit
(NCEL) modeled after OSHA Permissible Exposure
Limits is established ("New
Chemicals Exposure Limits").
Once it has been established that a chemical is hazardous, it is then the manufacturer's
responsibility to communicate this information to the
end user. In academic research and
development labs the EPA has been more effective in enforcement due to the fact that
they are not as limited as OSHA is to protecting only paid employees; thus,
the EPA can
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more effectively address potential exposure issues with students. In the workplace, in
addition to the claim that the EPA has to limiting worker exposure to hazardous
materials, OSHA bears a good portion of the enforcement burden through its Hazard
Communications Standard, CFR 1910.1200, which includes training, labeling and
material safety data sheet requirements. OSHA would then cover any workplace
exposure issues using the Chemical Hygiene Standard, 40 CFR 1910.1450 and by using
the general duty clause, 29 USC 654 (ATL International).
OSHA can also promulgate safety and health regulations bymeans of consensus
standards.
Voluntary consensus standards are developed by
organizations with the participation of interested parties
producers, users, and general interest groups [...] The
advantage ofutilizing the private sector's technical
expertise in formulating health, safety, and environmental
regulatory standards cannot be overemphasized. It is a fact
that this expertise cannot be matched, in the vastmajority
of instances, by the technical staffs of federal, state, and
local regulatory authorities. In addition, the utilization of
active technical standards-writing committees from the
private sector is an efficient and dependable means of
ensuring that standards are kept up to date with developing
technology. (Forrest 10)
Coincidentally, one such consensus standard organization, the AmericanNational
Standards Institute (ANSI) announced the "formation of the Nanotechnology Standards
Panel (ANSI-NSP), a new coordinating body for the development of standards in the area
of
nanotechnology"
(ANSI) on August 5, 2004.
A barrier to attaining a meaningful consensus standardmay be the proprietary nature
of the work performed to make nanoparticles. Therefore, a requirement or an incentive to
keep such information sequestered while allowing its use to develop andmaintain
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standards is imperative. The Royal Academies have gone a step further in their
recommendations and recommended that all safety related data pertaining to nanoscale
materials be released to the public domain ("Nanoscience and
nanotechnologies"
83).
Millions ofpeople will be working with these materials which, ifhandled improperly,
could pose a significant health risk to exposed individuals. Granted, not all constructs
will be found to be hazardous; however, as the industry grows there will be more and
more types of compounds created that will provided a wide range ofbenefits but also
present new risks. As a result, a regulatory frameworkmust be set up that is both
effective and flexible enough to allow for innovation not only in the creation ofnew
nanomaterials but also in the control of their exposures.
5.6 Proposal of a Specific ControlMethodology
Itmay be useful to use as a model the National Institute ofHealth (NIH) biosafety
levels and the European Union's chemical control banding methodology to formulate an
effective and adaptable set of containment standards to address hazards associated with
discreet classes ofnanomaterials. For instance, physical characteristics ofparticles could
be taken into account inwhich particle size, the presence of transitionmetals in and on
the construct, the ability of the material to be made airborne and/or penetrate the skin and
other parameters could be taken into account and applied to a set of
"Nanosafety"
guidelines which are based on engineering controls, personal protective equipment and
administrative practices.
The biosafety precautions employed to protect workers are based on the risk group
designation assigned to the pathogen of interest. Each risk group category is based on the
ability of a pathogen to cause disease and death. Risk group 1 is composed of
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microorganisms that rarely cause harm while pathogens in Risk group 4 can cause
disease and death. Although there are exceptions to the rule, generally a microorganism
in risk group 1 is handled at a biosafety level 1 and so on up through risk group and
biosafety level 4 which addresses pathogens presenting the highest hazard ("Appendix
B"). But there is some flexibility built into the system in that a pathogen such as monkey
virus B, which can be deadly if contracted, is categorized as risk group 3 and is generally
handled at a biosafety level 2. This exception applies because the virus is not easily
transmitted. This type of flexibility would be necessary to deal with the unique issues
presented by nanomaterials while providing a framework of risk classification and
control.
To demonstrate this approach, a hypothetical
'Nanosafety'
Guide for work in research
and development laboratories has been developed (see Table 1). For the purposes of this
demonstration the following nanoscale constructs are used:
- Embedded nanomaterials are presumed to be low risk or risk group 1 .
- Single walled carbon nanotubes would fall into the risk group 2 category since
they are presumed not to be made readily airborne and as such present
an
inhalation hazard only if significantly disturbed.
- Free quantum dots are thought to fall into the risk group 3 category. It is
presumed that they can be made readily airborne without the
benefit of
containment in liquid and are toxic by inhalation.
The control measures noted in this table are for demonstration purposes only and should
not be construed as effective precautionary measures endorsed by the author.
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The chemical control banding procedure is also of interest because it provides a
standardized means of communicating hazard and risk information to the end-user.
Control banding is a risk based exposure control system set up by the EuropeanUnion
(EU) for small to medium businesses and emerging economies where chemical safety
expertise may not be readily available. It involves the use ofR phrases that in the EU
must be assigned to hazardous chemicals. These R phrases have been standardized and
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organized by industry toxicologists into hazard groups. By reading the R phrases on the
container label ormaterial safety data sheet, the consumer is informed of the product
hazards and then is responsible to perform an exposure assessment of the work place.
Several exposure assessment parameters are defined and questions based on these
parametersmust be answered. The questions relate to the amount ofmaterial used, its
volatility based on boiling point and the temperature at which it will be handled. The
consumer then applies the results of the assessment to a simple table which is keyed to
specific information on one of three control approaches. Three broad control approaches
are then applied to the situation to control exposure and reduce or eliminate risk. The
control technologies used are: general ventilation; engineering control; containment
(Jackson 1).
A similar communication and control approach could be applied to nanomaterials.
Each unique nanomaterial constructwould be assigned to one ofvarious risk groups
based primarily on the physical and chemical hazards presented by each construct. Once
the constructwas characterized by hazard, a set of containment strategies and other
protective measures would be cross-referenced and applied to handling this material in
the workplace.
Currently, there is no information available on specific containmentmethods for
working with nano-scale materials. As mentioned earlier, HEPA filtration should work
theoretically but its use has not been approved by NIOSH for that purpose. Also the use
of apparatus such as biosafety cabinets or fume hoods may not be viable due to the air
currents necessary for containment and vibrations generated by the operation of these
units. Vibration and its avoidance is an important consideration in the siting of
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nanotechnology research facilities (Rossrucker). Presumably, sealed glove boxes and
other containment engineering controls which protect the worker and do not rely on the
continual operation of fans and motors to control these units may be ofpractical use. It
has also been suggested that production processes where dusts are generated be carried





While there is adequate information available to raise questions concerning the safety
of exposures to free nanoparticles, the current state ofknowledge concerning the
occupational exposure risks associated with nanotechnology is poor. There have been
several preliminary toxicological studies performed using actual nanomaterials, but none
have been associated with actual human exposures. The majority ofpotential evidence
concerning potential health effects comes from the work performed with ultrafine particle
exposures. The results from these studies suggest that there are significant pulmonary
and cardiovascular effects as well as extra-cardiopulmonary impacts on organs, such as
the liver, occurring as a result of exposure to UFPs entering the bloodstream from
inhalation exposures (Donaldson and Stone 409; Borm 316; Ferin et al. 383).
Additionally, ultrafine particles are able to cross the blood brain-barrier and potentially
affect the central nervous system (G. Oberdorster 444). Thus, there is significant
evidence that ultrafine particles and, by association, nanoparticles may present significant
health risks.
In "Nanoparticles: An occupational hygiene
review,"
Aitken, Creely and Tran state
that there is inadequate knowledge concerning nanoparticle risks to perform proper and
effective risk assessments; the components ofwhich include hazard identification, dose-
response assessments, exposure risk and risk characterization ("Risk Assessment for
Toxic Air Pollutants"). Areas requiring further study include providing sufficient
understanding of the toxicological risks (including potential routes of exposure) posed by
each specific nanoscale construct. Also additional work must be done to establish proper
risk assessment protocols, ametric by which surface area (for inhalation exposures) can
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be measured and an effective, validated means ofmonitoring exposure. Additional
informationmust also be gathered on an effective means ofbetter controlling presumed
exposures (Aitken, Creely and Tran 55-56) not only through personal protective
equipment but through engineering and administrative controls. Regulatory bodies must
also assess nanotechnology and determine if the existing regulations adequately control
the hazards posed by these materials. In areas where regulation is lacking but thought
necessary, appropriate actionmust be taken in relation to the risk posed.
Overall there were no significant disagreements concerning nanotechnology found by
this author other than the call for amoratorium for use ofnanomaterials from ETC
Executive Director; no other stakeholders have expressed concerns with such urgency.
Another area ofdisagreement is the role of transitionmetals on the surface chemistry and
toxicity of carbon nanotubes. Shvedova et al. states that these metals cause higher
toxicity than nanotubes without such transition metals being present
("Bronchial"
100).
Conversely, Brown et al. states that the metals do not contribute to the toxic effects of
nanotubes (690). No other areas of significant disagreement were found.
It is premature to assume, based on the available information, that one can develop an
effective and definitive set ofprecautionary recommendations to work safely with
nanomaterials. "For exposure by inhalation, control approaches and methods are
available which should be effective in nanoparticle processes"(Aitken, Creely Tran 57).
Presently though, no definitive and specific control recommendations or rules are
available from any public agency. However, included in Appendix A are two standard
operating procedures for working with nanomaterials in the research and development
setting which may be useful as a tool to complement an existing nanosafety program.
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Several assumptions were made including, but not limited to, the efficacy ofHEPA filters
to adequately capture nanoparticulates and the ability ofnitrile gloves to protect the skin
from nanoparticle infiltration.
As mentioned previously, an important method of reducing inhalation exposure is the
use of liquids to contain nanomaterials. It has been assumed theoretically that HEPA
filtration will be an effective means ofpreventing inhalation exposures. HEPA filtration
via respiratory protection rather than through the use of engineering controls is currently
emphasized in the literature. However, "for dermal or ingestion exposure, control
methods based on personal protective equipment may not be as effective as they are in
existing
process"
(Aitken, Creely Tran 57). Thus the control of significant potential
exposures and their control have not been adequately addressed at this time.
It is presumed that once the identified government initiatives complete their missions
there will be a frame work implemented to address the hazards posed by existing and new
constructs as they are introduced in the workplace. The risk assessment process must be
efficient and as effective as possible to meet the demands of this growing field.
Regulation will also necessary. There appears to be an adequate basis to handle some
of the preliminary problems associatedwith this materials within the existing regulatory
framework. However, specific sets of standards should be developed to classify
nanoparticulates by hazard and address potential exposure issues in the work place
through the use of appropriate engineering controls and personal protective equipment.
Conversely, these standards must be flexible enough to allow for innovation both within
the industry itself and in the development ofprotective measures.
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There are many questions that must be answered in order to work safely with
nanomaterials and also to reduce or eliminate any potential environmental effects this
material may have. Until these questions are answered, it is imperative that a
precautionary approach be adopted thatwill allow work to continue but ensure that







Research and Development Laboratories
Note: These SOPs are for demonstration purposes only and do not constitute
recommendations to work safely with nanomaterials.
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SOP-1
Standard Operating Procedures for Nanomaterials
1.) INFORMATION AND TRAINING
Prior to the initiation ofwork with nanomaterials, each staffmember must review
the material safety data sheet and any additional manufacturer's information on
the safe handling of and health risks associated with the particular construct.
Personnel must also have Nanosafety, Personal Protective Equipment, Hazard
Communication and Chemical Hygiene Training and as well as training on the
specific hazards posed by this material. Additionally, aNanosafety Planmust be
written (and reviewed by all affected personnel) which documents in detail all
procedures and specifies engineering controls, personal protective equipment and
any administrative controls use to work safely with these materials.
1.) PERSONAL PROTECTIVE EQUIPMENT (PPE)
Personnel working with nanoparticulates will wear two pairs ofnitrile gloves*,
disposable forearm guards, lab coats or gowns and safety eyewear. Respiratory
protection (N-99 respirators) must be used if a glove box, Class II biological
safety cabinet (BSC) or fume hood is not used or the plane of the open hood or
cabinet is breached by personnel. For work with sharps remember to set up the
area with a sharps container prior to initiation ofwork. Always dispose of the
sharps immediately after use. (*The proper type of glove to wear varies by the
hazardousmaterial handled. Consult the MSDS for the proper glove type to wear
when working with this compound.)
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2.) CONTAINMENT
All work will take place in a posted room or cubicle where access can be
restricted. Prior to the start of the project and where needles are used, the work
area must be staged with a sharps containerwithin easy reach. All used needles
must be disposed of IN the sharps container immediately after use. Re-capping is
not recommended but if it must be done a one-handed technique must be used.
All nanomaterials will be prepared and handled in a glove box, fume hood or
Class II BSC. Use of a negative pressure enclosure, such as a cubicle room is
permitted onlywhen the configuration of the glove box, BSC or hood will
interfere with proper handling technique. All personnel inside the negative
pressure enclosuremust use PPE as required above including adequate respiratory
protection.
3.) EMERGENCY PROCEDURES
In the event of skin contact, immediately remove contaminated clothing. For
small area exposures wash with soap and water continuously for 15 minutes. For
large area exposures use the nearest available emergency shower immediately and
wash for 15 minutes. In case of eye contact, promptly flush the eye(s) in an
eyewash station with copious amounts ofwater for 15 minutes with lifting both
eyelids occasionally and obtain medical attention. If the nanomaterials are
ingested or injected, obtain medical attention immediately. If large amounts of
nanomaterials are inhaled, move to fresh air and seek medical attention at once.
All spills in a glove box, BSC or fume hood will be cleaned up immediately by
personnel using proper PPE. The spill will be cleaned up using absorbent
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material and placed in a sealed container. For dry spills, wet methods must be
used to reduce the risk of generating airborne contaminants. The area will then be
decontaminated using a strong alkaline detergent or other appropriate solution
(see Section 4). If a spill occurs outside a BSC or hood, the room will be
evacuated. Reentry will not occur until the room is clear of airborne
contaminants, usually one hour. Spill response personnel will donN-99
respirators or SCBAs, goggles, chemical resistant gloves, a disposable smock or
lab coat and shoe covers. The spill will be contained and cleaned up the spill as
outlined above. All spills must be reported immediately to the EHS Department.
4.) DECONTAMINATION
Generally, methods ofdecontamination will vary with the compound used.
Contact the EHS Department for information concerning the proper
decontamination procedure.
5.) DISPOSAL OFWASTE
Waste is to be placed in special closable and sealed containers and disposed of as





Standard Operating Procedures for Nanomaterials and
Research Animals
1.) INFORMATION AND TRAINING
Prior to the initiation ofwork with nanomaterials each staffmember must review
the material safety data sheet and any additional manufacturer's information on
the safe handling of and health risks associated with the particular construct.
Personnel must also have Nanosafety, Personal Protective Equipment, Hazard
Communication and Chemical Hygiene Training and training on the specific
hazards posed by this material. Personnel caring for the contaminated animals
must haveNanosafety, Personal Protective Equipment, Animal Facility Safety
and Hazard Communication Training as well as specific instruction on the
hazards of the material used and methods for reducing one's exposure during the
care of shedding animals. Additionally, aNanosafety Planmust be written (and
reviewed by all affected personnel) which documents in detail all procedures and
specifies engineering controls, personal protective
equipment and any
administrative controls used to work safely with these materials.
1.) PERSONAL PROTECTIVE EQUIPMENT (PPE)
Preparation and Administration of the Hazardous Agent: Personnel working
with nanoparticulates will wear two pairs ofnitrile gloves*, disposable forearm
guards, lab coats or gowns and safety eyewear. Respiratory protection (N-99
respirators) must be used if a glove box, Class II biological safety cabinet (BSC)
or fume hood is not used or the plane of the open hood or cabinet is breached by
personnel. For work with sharps, remember to set up the area with a sharps
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container prior to initiation ofwork. Always dispose of the sharps immediately
after use. (*The proper type ofglove to wear varies by the hazardous material
handled, consult theMSDS for the proper glove type to wear when working with
this compound).
Maintenance of the animals: Personnel will wear two pairs ofnitrile gloves*, N-
99 respirators, gowns or lab coats, shoe covers and safety eyewear when
maintaining the animals. Cages must be changed in a glove box, fume hood, Class
II BSC or equivalent cage dump station. (*The proper type of glove to wear
varies by hazardous material handled, consult theMSDS for the proper glove type
to wearwhenworking with this compound).
2.) CONTAINMENT
Administration: All work will take place in a posted room or cubicle where
access can be restricted. Prior to the start of the project and where needles are
used, the work area must be staged with a sharps container within easy reach. All
used needles must be disposed of to the sharps container immediately after use.
Re-capping is not recommended but if itmust be done a one-handed technique
must be used. All nanomaterials will be mixed, aliquoted for administration and
administered in a glove box, fume hood or Class II BSC. Use of a negative
pressure enclosure, such as a cubicle room, to perform administration is permitted
only when the configuration of the glove box, BSC or hood will interfere with
proper administration technique. All personnel inside the negative pressure
enclosuremust use PPE as required above including adequate respiratory
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protection. Only experienced personnel and those adequately trained in the
specific technique will administer the compound to the animals.
Housing: Access will be restricted to authorized personnel. All contaminated
animals will be housed inmicro-isolator cages with properly fitted tops or HEPA
filtered Thoren racks. All cages will be labeled with hazard warnings. Unless the
investigator can provide written evidence of the animals not excreting the
nanomaterials, the EHS Officer will determine the proper amount of time the
animals will be housed and handled as potentially contaminated (shedding).
Maintenance: During the period of shedding, Animal Facility personnel will
change the cages only in a glovebox, chemical fume hood, Class EI BSC or
equivalent cage dump station in a posted room where access can be restricted.
Waste is to be placed in red bags and leak proof containers for disposal as
infectious chemo waste over this time period.
3.) EMERGENCY PROCEDURES
In the event of skin contact, immediately remove contaminated clothing, for small
area exposures wash with soap andwater continuously
for 15 minutes. For large
area exposures use the nearest available emergency shower immediately andwash
for 15 minutes. In case of eye contact, promptly flush the eye(s) in an eyewash
station with copious amounts ofwater for 15 minutes with lifting both eyelids
occasionally and obtainmedical
attention. If the nanomaterials are ingested or
injected, obtain medical attention immediately. If large amounts ofnanomaterials
are inhaled, move the person to fresh air and seekmedical attention at once.
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All spills in a glove box, BSC or fume hood will be cleaned up immediately by
personnel using proper PPE. The spill will be cleaned up using absorbent
material and placed in a sealed container. For dry spills, wet methods must be
used to reduce the risk of generating airborne contaminants. The area will then be
decontaminated using a strong alkaline detergent or other appropriate solution
(see Section 4). If a spill occurs outside a BSC or hood, the room will be
evacuated. Reentry will not occur until the room is clear of airborne
contaminants, usually one hour. Spill response personnel will don N-99
respirators or SCBAs, goggles, chemical resistant gloves, a disposable smock or
lab coat and shoe covers. The spill will be contained and cleaned up the spill as
outlined above. All spills must be reported immediately to the EHS Department.
4.) DECONTAMINATION
Generally, methods ofdecontamination will vary with the compound used.
Contact the EHS Office for information concerning the proper decontamination
procedure.
5.) DISPOSAL OFWASTE
Waste is to be placed in special closable containers during the time period the
animals are presumed to be shedding and disposed of as infectious chemo waste.
Carcasses will be disposed of as infectious waste and nanomaterial waste will be
disposed of as hazardous chemical waste. Spill clean-up waste will be disposed






1.) Can you directme to any information concerning nanotechnology and risk, toxicology
or any other health and safety study that has been done on any aspect of this technology?
2.) Can you recommend engineering controls to prevent potential inhalation of
nanoparticles?
3.) Are you aware of any papers that cover the use of engineering controls with
nanomaterials?
4.) Do you have a contact atNIOSH or anywhere else that is looking at engineering
controls for nanoparticulates?
5.) I was hoping to get information on best safety practices when working with
nanomaterials, primarily engineering controls and personal protective equipment. Do
you have any information?
6.) Do HEPA filters work for nanomaterials?
7.) Since nanomaterials behave in ways similar to gases, will adsorptionmedia such as
charcoal work for filtering out airborne nanoparticulates?
8.) Can you use an electrostatic precipitator to capture nanoparticles?
9.) Can I get information on the regulatory procedures involvedwith getting a new
chemical regulated under TSCA? In particular, when is a risk assessment done and how
is that information translated to the regulation of that substance in the workplace, through
OSHA for instance?
10.) What regulation, if any, is necessary for nanomaterials?
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